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Abstract 
A SURVEY OF CANNABIS CONSUMPTION AND IMPLICATIONS OF AN 
EXPERIMENTAL POLICY MANIPULATION AMONG YOUNG ADULTS 
 
By Alyssa Rudy B.S. 
 
A thesis proposal submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2018. 
 
Major Director: Dr. Caroline Cobb, Assistant Professor, Department of Psychology 
 
The purpose of this online cross-sectional study was to identify cannabis user profiles by 
administration method and examine how differential cannabis policies influence intentions 
among young adults. Participants were assigned randomly to one of three hypothetical cannabis 
policy conditions (recreationally legal; medically legal; illegal). Within conditions, participants 
completed measures regarding cannabis use, including administration methods, cannabis 
attitudes, norms, perceived behavioral control, self-efficacy, and intentions. Latent class analysis 
(LCA) was used to determine sub-groups of past 30-day cannabis users by administration 
method followed by sub-group comparisons. Condition effects on intentions and associated 
variables were examined using ANCOVA. Four classes (Low-Blunt, Low-Bong, Mod-Poly, 
High-Poly) differing in demographics and tobacco use were identified. Recreationally and 
medically legal policy conditions resulted in more favorable cannabis attitudes, higher self-
efficacy, and higher intentions to use compared to the illegal policy condition. Results inform 
cannabis intervention efforts and longitudinal research on the effects of cannabis policy changes. 
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Introduction 
Overview and Motivation 
Cannabis, a well-known drug class used for recreational and medicinal purposes, is the 
most frequently used illegal drug in the United States (US; Center for Behavioral Health 
Statistics and Quality [CBHSQ], 2015). Prevalence trends demonstrate that in the past decade, 
past 12-month use of cannabis has increased from 4.1% to 9.5% among US adults (Hasin et al., 
2015). Despite little change in US federal cannabis restrictions, during this same time, state-level 
cannabis policies have been evolving rapidly regarding medicinal use as well as recreational use. 
The changes in cannabis policy warrant investigation in order to reduce the potential harms of 
cannabis legalization. Cannabis policy changes affect the methods in which cannabis is 
consumed, patterns of cannabis use, and the types of individuals who consume cannabis 
(Borodovsky, Crosier, Lee, Sargent, & Budney, 2016; Hanson, 2016). 1 Differential consumption 
methods may be associated with different use patterns, health-related effects, and (e.g., 
demographic) predictors and correlates of cannabis use. Information is needed to address gaps in 
knowledge regarding cannabis user profiles by consumption method as well as examine how 
differential policy environments may influence cannabis use intentions, particularly among 
individuals at high risk for dependence such as young adults.  
Cannabis: Cannabinoids, Concentrations, and their Health Effects  
The cannabis plant (genus: Cannabis) has several well-characterized strains/species 
including Cannabis sativa, Cannabis indica, and Cannabis ruderalis (Sawler et al., 2015). Each 
                                                 
1 Consumption refers to any type of cannabis use including inhalation, eating, and drinking. Ingestion 
refers to eating and drinking. 
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species contains different cannabinoid contents, and each prompt a variety of subjective effects. 
Pure Cannabis sativa elicits subjective cerebral effects while pure Cannabis indica varieties are 
well-known for their sedative effects (Sawler et al., 2015). Many varieties that are used for 
consumption are sexually propagated hybrids that contain genes from both cannabis sativa and 
cannabis indica (Cervantes, 2006; Emboden, 1974). Cannabis ruderalis is not consumed 
commonly due to its low levels (approximately 0.2%) of cannabis’ primary psychoactive 
cannabinoid, Δ9-tetrahydrocannabinol (THC; Beutler, 1978; Sawler et al., 2015). In all cannabis 
species, the flowering tops and leaves, which are harvested typically for consumption, contain 
the highest amounts of psychoactive cannabinoids (Adams & Martin, 1996). Cannabinoids, such 
as THC, are a class of chemical compounds that are found endogenously (e.g., anandamide) as 
well as from exogenous sources such as the cannabis plant that interact with specific cannabinoid 
receptors in the brain and other areas of the body (Ameri, 1999). 
Cannabinoids, their receptors, and the physiological responses of the interaction between 
cannabinoids and cannabinoid receptors are contained in the endocannabinoid system (Aizpurua-
Olaizola et al., 2016; Mechoulam & Parker, 2013). The cannabis plant contains over 400 
chemical constituents of which over 109 are cannabinoids that interact with primarily two 
cannabinoid receptors: CB1 and CB2 receptors (El-Alfy et al., 2010; Mehmedic et al., 2010). 
Cannabinoid receptors are located in the central and peripheral nervous system of the body. CB1 
receptors are mainly concentrated in the brain while CB2 receptors are located primarily in 
immune cells. Most research has focused on three cannabinoids in the cannabis plant: THC 
(primary psychoactive chemical), cannabinol (CBN; psychoactive but less powerful than THC), 
and cannabidiol (CBD; not psychoactive but has other therapeutic properties; Sharma, Murthy, & 
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Bharath, 2012). When extracted, THC is a volatile viscous oil that is highly lipophilic and can be 
detected in plasma within seconds after inhalation (via combusted cannabis; Grotenhermen, 
2003; Sharma et al., 2012). Oral administration of cannabis results in a slower delivery of THC 
as well as time to peak plasma concentration (Grotenhermen, 2003). The lipophilic nature of 
THC is related to the distribution pattern within the body resulting in concentration in the brain 
and vascularized tissues (Grotenhermen, 2003). Metabolism rates vary dependent on the pattern 
of use, dose, and biological measure (e.g., plasma, urine), but urine assays can detect THC 
metabolites for up to 12 days following use (Law, Mason, Moffat, Gleadle, & King, 1984).  
Cannabis consumption (mediated primarily by the cannabinoids consumed) affects the 
brain, body, and behavior in a variety of ways. Dose and route of administration are important to 
consider when examining effects associated with cannabis consumption. Some acute effects such 
as delusions, hallucinations, and depersonalization are observed typically at only high doses but 
are generally short lasting (Advokat, 2014). Recent reports of THC concentration in seized dried 
cannabis has increased from 3% in the 1980s to about 12% in 2014 (ElSohly et al., 2016; 
Volkow, Baler, Compton, & Weiss, 2014). In contrast, THC concentration for cannabis 
concentrates is between 60% and 80% (Stogner & Miller, 2015b). These differences in 
concentration may influence associated patterns of cannabis use and related health effects.   
 Acutely, cannabis use induces feelings of euphoria and relaxation and can result in 
impaired memory, decreased performance in cognitive tasks, decreased reaction time, and 
negative mood-type effects including panic and paranoia (Ameri, 1999; Sharma et al., 2012). 
The pleasurable and rewarding effects of cannabis, particularly THC, are linked primarily to the 
widespread use and abuse of this substance (Ameri, 1999; Cooper & Haney, 2009). Like other 
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drugs of abuse, THC activates the mesolimbic dopamine system, a brain area critical for 
reinforcing drug-taking behavior (Tanda, Pontieri, & Di Chiara, 1997). Other negative health 
effects of cannabis use include suppression of antibody production in the immune system, 
increased heart rate, and hypotension (Ameri, 1999; Franz & Frishman, 2016; Rieder, Chauhan, 
Singh, Nagarkatti, & Nagarkatti, 2010). Initiation of cannabis use among adolescents and young 
adults can also affect the developing brain resulting in impaired neuronal connectivity (Zalesky 
et al., 2012), particularly in the prefrontal cortex (Filbey & Yezhuvath, 2013; Gogtay et al., 
2004).  
Importantly, in addition to the effects associated with abuse potential and negative health 
consequences, cannabinoids also are associated with medically relevant and therapeutic health 
effects. Cannabis consumption can produce analgesic, antiemetic, and anticonvulsive effects 
(Ameri, 1999; Holland et al., 2006). Prior research suggests that cannabis consumption is 
beneficial for cancer patients who experience nausea and other negative side effects from 
chemotherapy treatments (Carlini & Cunha, 1981; Holland et al., 2006; Rivera-Olmos & Parra-
Bernal, 2016; Schrot & Hubbard, 2016). Studies show that CBD helps combat Alzheimer’s 
disease (Karl, Garner, & Cheng, 2016), multiple sclerosis (Patti et al., 2016), and epilepsy 
(Ameri, 1999; Leo, Russo, & Elia, 2016; Lippiello et al., 2016). This diverse range of positive 
and negative effects and the risks to younger populations who may initiate cannabis use creates 
challenges for cannabis policy and regulation as well as research efforts in this area.  
In recent years, the availability of new recreational cannabis forms (i.e., concentrates) and 
consumption methods (i.e., electronic heating systems/vaporizers and concentrate/dab rigs) have 
increased with little data available concerning their relative health effects. Historically, cannabis 
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has either been consumed by combustion (i.e., smoked) or taken orally (often by mixing with 
food; Adams & Martin, 1996; Sharma et al., 2012). As described above, average THC 
concentration varies between dried leaves versus concentrates, and THC dose is vital to 
understanding the acute effects experienced. In one clinical demonstration, dried cannabis plants 
and synthetic THC preparations (controlling for THC concentration) that were either smoked or 
ingested orally (via brownies) produced similar dose-dependent effects and subjective effects 
when compared between products (i.e., dried cannabis vs. synthetic THC). Unfortunately, these 
results were not examined by consumption method (i.e., smoked THC vs. oral THC ingestion; 
Wachtel, ElSohly, Ross, Ambre, & de Wit, 2002).  More research is needed on the differential 
health effects of cannabis forms (e.g., dried vs. concentrate) and methods of cannabis 
administration.  
Most of the data available only have examined effects of dried and combusted cannabis. 
Similar to the health effects observed for combusted tobacco use, combusted cannabis use is 
associated with increased coughing and mucus, increased risk of lung disease, exposure to 
carbon monoxide, and the potential to develop lung cancer (Martinasek, McGrogan, & 
Maysonet, 2016; Yayan & Rasche, 2016). Other forms of cannabis use may elicit unique health 
effects. For example, oral cannabis consumption and/or cannabis chewing may not result in 
combustion-related side effects but instead produce mouth irritation and other adverse changes to 
the oral epithelium (Cho, Hirsch, & Johnstone, 2005). Data from an internet sample of cannabis 
users indicated an association between cannabis use via vaporizer (electronic heating system) 
and fewer respiratory symptoms controlling for a host of associated factors relative to cannabis 
users who did not use a vaporizer (Earleywine & Barnwell, 2007). The current literature on 
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effects of cannabis concentrates is small; however, preliminary studies suggest that use of 
cannabis concentrates contributes to a higher incidence of fainting, potential for higher cannabis 
withdrawal symptoms due to elevated THC content, potential dangers from consumption of 
products made with butane, and an increased risk of psychosis (Di Forti et al., 2015; Loflin & 
Earleywine, 2014; Miller, Stogner, & Miller, 2016; Stogner & Miller, 2015a). Taken together, 
these data support better assessment of cannabis use in terms of dose and consumption method to 
better understand the health implications of these use patterns. These data also indicate that there 
may be differential health effects between methods of cannabis administration; therefore, use 
patterns of these methods must be further explored.  
Trends in Cannabis Use, Abuse, and Dependence  
In concert with or potentially in response to evolving cannabis preparations and 
consumption methods, current (past 30-day) cannabis use among people over 12 years old has 
increased from 14.5 million in 2007 to 22.2 million in 2014 (CBHSQ, 2015). Among those aged 
14 to 17 years in 2013, cannabis was the most highly used drug (NIDA, 2015). For young adults 
(aged 18-25), past month cannabis use was 20.8% in 2016, which is a 4.9 percentage point rise 
from 2004 (CBHSQ, 2015, 2017). Among US adults at large, past month cannabis use was 7.2% 
in 2016, an increase of almost 3.1 percentage points since 2002 (CBHSQ, 2017). Specifically, in 
Virginia, past 30-day cannabis use among 18-25 year olds was 17.8% in 2016, which is lower 
than national prevalence rates for this age group (See Table 1). Among adults aged 26 or older in 
Virginia, past 30-day cannabis use was also lower than nationwide rates in 2016. However, these 
nationwide and Virginian trends suggest that overall cannabis use in multiple age groups is 
increasing at a moderate rate. 
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Table 1. Nationwide and Virginian Prevalence Estimates of Cannabis Use by Age 
 Nationwide estimates Virginia estimates 
 Past year cannabis 
use 
Past 30-day 
cannabis use 
Past year cannabis 
use 
Past 30-day 
cannabis use 
Youth  
Aged 12-17 12.0% 6.5% 11.4% 5.4% 
Young adults 
Aged 18-25 33.0% 20.8% 30.1% 17.8% 
Adults 
Aged 26+ 
11.0% 7.2% 8.5% 6.7% 
Note: Virginian estimates from the 2015 NSDUH (CBHSQ, 2016). Nationwide estimates from 
the 2016 NSDUH (CBHSQ, 2017). 
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As defined by the American Psychiatric Association (APA) Diagnostic and Statistical 
Manual for Mental Disorders, fifth edition (DSM-5), cannabis substance use disorder is  
classified by the presence of two or more criteria occurring within a 12-month period (APA, 
2013). Many of the nationally representative monitoring systems have not transitioned to this 
current definition and instead utilize substance use dependence and abuse classification 
guidelines from the Diagnostic Statistical Manual for Mental Disorders, fourth edition (DSM-
IV). Similarities and discrepancies between these categorizations are displayed in Table 2. As is 
apparent, the newer cannabis use disorder definition incorporates all of the previous cannabis 
dependence use criterion and the majority of the abuse criterion with one addition, the presence 
of craving or strong urges to use the substance (BehaveNet, 2016). 
Due to the recent changes in diagnostic criterion, the available data collapses cannabis 
use and abuse categories in order to identify the prevalence of cannabis use disorder. Although 
current cannabis use has increased, the prevalence of cannabis use disorders among those aged 
12 and older has decreased from 1.8% in 2002 to 1.6% in 2014 (CBHSQ, 2015). For young 
adults (aged 18-25), cannabis use disorder decreased from 6.0% in 2004 to 4.9% in 2014 
(CBHSQ, 2015). Among US adults, cannabis use disorder slightly increased from 0.8% in 2002 
to 0.9% in 2014 (CBHSQ, 2015). Taken together, national data across multiple groups suggest 
that overall cannabis use is increasing moderately while the prevalence of cannabis use disorders 
has experienced little change over the same time period. These discrepancies in cannabis use and 
disorder incidence may be due to changes in substance disorder criteria as well as lagged effects 
in disorder development. Continued surveillance is essential to better understand these trends.   
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Table 2. Comparison of Substance Use Disorder, Substance Use Dependence, and Abuse Criterion by DSM Edition 
 
DSM-5 (APA, 2013) DSM-IV-TR (BehaveNet, 2016) DSM-IV-TR (BehaveNet, 2016) 
Cannabis use disorder Substance (marijuana) use dependence Substance (marijuana) abuse 
A problematic pattern of cannabis use leading to clinically 
significant impairment or distress, as manifested by at least 
two of the following, occurring within a 12-month period: 
A maladaptive pattern of substance use, leading to clinically 
significant impairment or distress, as manifested by three (or more) 
of the following, occurring at any time in the same 12-month period: 
 A maladaptive pattern of substance use leading to 
clinically significant impairment or distress, as 
manifested by one (or more) of the following, 
occurring within a 12-month period 
Tolerance, as defined by either of the following: 
- A need for markedly increased amounts of cannabis to 
achieve intoxication or desired effect. 
- Markedly diminished effect with continued use of the same 
amount of cannabis. 
 Tolerance, as defined by either of the following: 
- a need for markedly increased amounts of the substance to 
achieve intoxication or desired effect 
- markedly diminished effect with continued use of the same amount 
of the substance 
NA 
Withdrawal, as manifested by either of the following: 
-The characteristic withdrawal syndrome for cannabis. 
-Cannabis (or a closely related substance) is taken to relieve or 
avoid withdrawal symptoms. 
Withdrawal, as manifested by either of the following:  
- the characteristic withdrawal syndrome for the substance  
- the same (or a closely related) substance is taken to relieve or avoid 
withdrawal symptoms 
 NA 
A great deal of time is spent in activities necessary to obtain 
cannabis, use cannabis, or recover from its effects. 
A great deal of time is spent in activities necessary to obtain the 
substance, use the substance, or recover from its effects  
NA 
There is a persistent desire or unsuccessful efforts to cut down 
or control cannabis use. 
There is a persistent desire or unsuccessful efforts to cut down or 
control substance use  
NA 
Cannabis is often taken in larger amounts or over a longer 
period than was intended. 
The substance is often taken in larger amounts or over a longer 
period than was intended  
NA 
Continued cannabis use despite having persistent or recurrent 
social or interpersonal problems caused or exacerbated by the 
effects of cannabis. 
The substance use is continued despite knowledge of having a 
persistent or recurrent physical or psychological problem that is 
likely to have been caused or exacerbated by the substance 
NA 
Important social, occupational, or recreational activities are 
given up/reduced because of cannabis use. 
Important social, occupational, or recreational activities are given up 
or reduced because of substance use  
NA 
Recurrent cannabis use in situations in which it is physically 
hazardous. 
NA Recurrent substance use in situations in which it is 
physically hazardous  
Cannabis use is continued despite knowledge of having a 
persistent or recurrent physical or psychological problem that 
is likely to have been caused or exacerbated by cannabis. 
NA Continued substance use despite having persistent or 
recurrent social or interpersonal problems caused or 
exacerbated by the effects of the substance  
Recurrent cannabis use resulting in a failure to fulfill major 
role obligations at work, school, or home. 
NA Recurrent substance use resulting in a failure to fulfill 
major role obligations at work, school, or home.  
NA NA Recurrent substance-related legal problems (e.g., 
arrests for substance-related disorderly conduct) 
Craving, or a strong desire or urge to use cannabis. NA NA 
Note:  NA indicates non-applicable meaning there is no equivalent criteria within this edition
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Alternative Cannabis Consumption and Production Methods   
Most national assessments (e.g., National Survey on Drug Use and Health [NSDUH], 
Monitoring the Future [MTF], & Youth Risk Behavior Survey [YRBS]) typically evaluate 
cannabis use with broad questions which capture lifetime use, current use (e.g., past month), and 
age of initiation. Unfortunately, these general use questions do not capture the wide array of 
administration methods or forms available. Forms of cannabis include dried (i.e., cannabis in its 
original form), concentrates (e.g., butane hash oil, kief, shatter, wax, and rosin), and cooked 
cannabis (which includes tinctures, sprays, and cannabutter, for example). Concentrates, 
commonly known as dabs, kief, (butane) hash oil, wax, budder, and shatter, are products with 
elevated THC levels compared to traditional dried cannabis (Loflin & Earleywine, 2014; Raber, 
Elzinga, & Kaplan, 2015).  
Forms of cannabis can be consumed alone or in combination via a variety of methods of 
administration. Methods of cannabis administration include smoking or inhaling with joints 
(cannabis wrapped in a cigarette rolling paper; often but not always containing tobacco) and 
blunts (cannabis wrapped in tobacco leaves or hollowed cigars; often but not always containing 
tobacco) as well as use of bowls/pipes, bongs, hot knives, rigs, vaporizers, and edibles (Schauer, 
King, Bunnell, Promoff, & McAfee, 2016).  Bowls and pipes are devices most often made of 
glass and made in a variety of shapes and sizes (see Figure 1A). Cannabis is placed in the 
concave “head” of the bowl/pipe where it is combusted by a lighter or other heat source. Bongs 
are devices made from glass, plastic or other materials that are composed of a concave orifice 
(typically removable) where cannabis is placed and heated but with the addition of a bowl at the 
bottom of the device where water is placed (similar to hookah/waterpipe devices; see Figure 1A; 
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Kelly, 2005). Hot knives are commonly used with concentrated cannabis. Two metal knives are 
heated with a blowtorch or a kitchen stove and a small amount of cannabis concentrate is placed 
on the heated knife blades (Urbanremo, 2015). The cannabis is then inhaled in one of two ways: 
1) the knives are situated near the user’s mouth and the user inhales or 2) the knives are placed 
under a water bottle with a cut bottom and the user inhales through the top of the water bottle. 
Rigs are devices similar to bongs in which a glass, ceramic, or titanium rod (called a “nail”) is 
heated with a blowtorch or an electronic heating source (see Figure 2; Raber et al., 2015). Rigs 
are used exclusively with cannabis concentrates which immediately aerosolize upon contact with 
the nail, and the emissions are inhaled through the top of the device, similar to a bong (Loflin & 
Earleywine, 2014; Miller et al., 2016; Raber et al., 2015). Vaporizers are relatively modern 
electronic devices commonly known as electronic cigarettes (e-cigarettes) or e-hookahs (Figure 
1B; Breland et al., 2016). More commonly, these devices are used with nicotine-containing 
liquid (Breland et al., 2016); however, many devices are also manufactured specifically for use 
with dried cannabis flowers, cannabis concentrates, or cannabis containing liquid/oil (e.g. Pax, 
Atmos vaporizers, Quick draw; Figure 1B; D. C. Lee, Crosier, Borodovsky, Sargent, & Budney, 
2016). These devices contain a power source (battery), heating element, or atomizer that, when 
activated, warms to a temperature that produces an aerosol to be inhaled (Breland et al., 2016; 
Giroud et al., 2015; D. C. Lee et al., 2016). Another method of cannabis consumption is 
ingestion of foods or drinks made with cannabis, commonly called “edibles” (Vandrey et al., 
2015). Tinctures are ingestible mixtures of cannabis and high-proof alcohol. The medical 
cannabis community commonly use tinctures, mixing them with food, drinks, or placing small 
doses directly into their mouths (Schnelle, Grotenhermen, Reif, & Gorter, 1999).   
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Figure 1. Devices for cannabis consumption. Panel A displays typical glass devices including a 
bong, rig, and bowl/pipe. Panel B displays electronic devices including a dry material vaporizer 
and an electronic cigarette where cannabis-containing liquid would be loaded.   
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Figure 2. A cannabis concentrate rig. A cannabis concentrate rig typically includes a dome 
(which helps contain the cannabis emissions) and a nail (where the concentrate preparation is 
placed).  
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Methods of cannabis production and product development have matured with the passing 
of medical and recreational cannabis laws. Traditionally, cannabis grows outdoors in soil; 
however, other forms of production such as indoor hydroponics are used to increase yields and 
decrease production time (Knight et al., 2010). Hydroponics is a method of growing cannabis, 
which does not use soil, but instead uses nutrient-rich water to grow plants. According to 
informal reports, indoor growing systems provide the most control over the growing 
environment with the use of LED or high-intensity discharge lights, exhaust fans, and 
temperature, humidity, and carbon dioxide regulation (Danko, 2016). After cultivation, the dried 
cannabis is kept in its original form or made into different forms such as concentrates and 
edibles. Growing cannabis often involves propagation and crossbreeding in order to create new 
species of cannabis (Beutler, 1978). Due to the legalitiy of cannabis, the rapid growth of the 
cannabis industry, and the development of new production technologies, the regulation and 
monitoring of cannabis production is extremely difficult. 
Limited research exists on the prevalence of specific methods or combinations of 
methods of cannabis consumption, but combustion-based methods appear to be the most 
commonly used by recreational cannabis users (Hindocha, Freeman, Ferris, Lynskey, & 
Winstock, 2016; J. R. Hughes et al., 2014; Schauer, King, et al., 2016). Baseline data from a 
study of US adult daily cannabis users during 2010-2012 showed that more than half reported 
weekly usual use of joints (53%), blunts (51%), pipes (55%), or bongs (32%) with fewer 
individuals endorsing use of vaporizers (6%; J. R. Hughes et al., 2014). Within this same study, 
participants’ daily use of cannabis, including consumption method, was monitored using an 
interactive voice response system; these data indicated that over 3 months, 59% used at least 
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three modes of cannabis consumption (joint, blunt, and pipe/bong/vaporizer) and fewer than 3% 
used only joints or only blunts. Pipe/bong use was the most prevalent method endorsed during 
daily monitoring (49% of days monitored) followed by blunts (33%) and joints (16%; J. R. 
Hughes et al., 2014). A more recent nationally representative sample of US adults collected in 
2014 indicated that among past 30-day users, the most common methods of use were pipe/bowl 
(50%), joint (49%), bong/water pipe/hookah (22%), and blunt/cigar (20%) with fewer 
individuals endorsing use of edibles (16%), vaporizer/electronic devices (8%), and cannabis in 
“other ways” (5%; Schauer, King, et al., 2016). Most users endorsed one method of use (59%) 
but almost 20% endorsed three or more; importantly results from this study did not distinguish 
which methods were most commonly used exclusively or in combination (Schauer, King, et al., 
2016).   
An online global (Europe, Australasia, and US/Americas) survey performed in 2013 
including over 70,000 participants examined past year cannabis use characteristics by route of 
administration focusing specifically on those consumed in combination with tobacco (i.e., joint 
with tobacco, pipe with tobacco) versus those without tobacco (i.e., joint without tobacco, pipe 
without tobacco, vaporizer; Hindocha et al., 2016). Overall results indicated tobacco-containing 
administration methods (i.e., joints with tobacco) were endorsed more highly (66%) by past year 
users, but the most common non-tobacco-containing method was pipe without tobacco (12%). 
US-specific results revealed an alternative pattern with non-tobacco methods emerging as the 
most common (92%) with the highest endorsement for pipe without tobacco (48%; Hindocha et 
al., 2016). Taken together, these data support the assertion that combustion-based methods are 
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likely the most common among US cannabis users, but importantly new trends, policies, and 
available methods of use are likely to influence these patterns of consumption.  
Inhalation and oral methods of administration may be increasing in some populations. 
The Association for Cannabis and Medicine (Cologne, Germany) administered an anonymous 
survey in Germany, Austria, and Switzerland in 1999 to examine use patterns of self-medicating 
cannabis users (Schnelle et al., 1999). Across their lifetime, almost half of the sample (49%) had 
used inhalation methods of administration, 14% had used oral methods, and 37% had used both 
inhalation and oral methods (Schnelle et al., 1999). The same researchers administered the 
survey again in 2001 in Germany and Switzerland (Grotenhermen & Schnelle, 2003). Over half 
of participants (56%) inhaled cannabis products while 17% consumed cannabis orally and 23% 
used both inhalation and oral methods (Grotenhermen & Schnelle, 2003). These results indicate 
that, in certain populations, the individual use of inhalation and oral methods of cannabis 
administration may have increased over time while the dual use of oral and inhalation methods 
decreased.  
The use of cannabis concentrates via rig or vaporizer specifically appears to be one of the 
newest consumption methods to gain popularity and is coupled with concerning reports of abuse-
related side effects associated with use. A Google Trends analysis between 2004-2015 which 
tracked the frequency of searches that included “dabbing” (i.e., concentrate use) and other 
similar terms indicated that prior to 2013 cannabis smoking and edible terms were searched more 
often than “dabbing” (Zhang, Zheng, Zeng, & Leischow, 2016). However, by 2015, “dabbing” 
searches were 28% higher than cannabis smoking terms and 58% higher than edible search terms 
(Zhang et al., 2016). An online US study conducted in 2014 included 357 adults who had used 
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concentrates in their lifetime (Loflin & Earleywine, 2014). Results showed that approximately 
one third (32%) of participants who had tried a vaporizer with concentrates preferred using a 
vaporizer instead of a hash oil rig. Data also indicated that the most endorsed reasons for using 
concentrates were that participants needed fewer doses to receive the same effect, the “high” was 
stronger, and the “high” felt subjectively different (Loflin & Earleywine, 2014). This data serves 
as an indication of the rapidly growing popularity of cannabis concentrates.  
Vaporizer use in particular appears to be prevalent in US adolescent and young adult 
populations. Among a 2014 sample of US high school students in Connecticut, 5% had ever used 
cannabis with a vaporizer (Morean, Kong, Camenga, Cavallo, & Krishnan-Sarin, 2015). When 
restricted to ever cannabis users, 18% had used cannabis with a vaporizer. The study also 
measured the type of cannabis product used in vaporizers (i.e., concentrates or dried cannabis). 
Among those who indicated lifetime cannabis use, 16% had used concentrates in a vaporizer 
while 23% had used dried cannabis in a vaporizer (Morean et al., 2015). Among a 2013 sample 
of US high school students in Colorado (assessed prior to implementation of retail marijuana 
availability), 20% reported past 30-day cannabis use with 85% of users indicating smoking as 
their usual mode of consumption followed by vaporizing (6%), edibles (5%), and other (4%; R. 
M. Johnson et al., 2016).  Among one sample of US undergraduate students in Arizona, past year 
cannabis use was reported by 44%, with cannabis vaping at 23%, and over half of past-year 
cannabis users had tried cannabis vaping in the past year (51%; Jones, Hill, Pardini, & Meier, 
2016).  
Importantly, vaporizer use for cannabis consumption is not limited to younger age 
groups. In an online sample of cannabis-using US adults in 2014-2015, 61% of the sample had 
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ever used a vaporizer to administer cannabis, with most indicating using a vaping pen (45%) or 
tabletop device (23%) followed by a portable device (15%) and e-cigarette (11%; D. C. Lee et 
al., 2016). Dual use of smoking and vaping cannabis was reported by 76% of the sample; 
smoking cannabis was still the most frequently used method and very few individuals reported 
vaping exclusively (D. C. Lee et al., 2016). An online study conducted in 2013 included 96 
adults who used a vaporizer with cannabis (Malouff, Rooke, & Copeland, 2013). The most 
endorsed reasons for using cannabis with a vaporizer were perceived health benefits, better taste, 
no smoke smell/discreetness, and users achieve more drug effects with the same amount of 
cannabis (Malouff et al., 2013) 
As presented above, patterns of cannabis consumption in the US are evolving, and while 
combustion-based methods still may be the most common, engagement in multiple methods is 
also prevalent. Differential consumption methods may be associated with varying use 
trajectories, patterns of consumption, psychoactive and health-related effects, and importantly, 
predictors and correlates of cannabis use. Of the latter, predictors and correlates may be most 
useful for informing the development of prevention or intervention efforts to reduce the negative 
consequences associated with cannabis use.  
Predictors and Correlates of Cannabis Use 
Available data suggests that a wide range of factors are predictive of cannabis use 
including demographics (i.e., race/ethnicity, gender), harm perceptions regarding cannabis use, 
and other risk-taking behaviors such as tobacco and alcohol use. Importantly, much of the work 
regarding predictive factors of cannabis use includes populations/settings outside of the US so 
consideration of the population studied is key when interpreting findings (Haug, Nunez, Becker, 
  
19 
 
Gmel, & Schaub, 2014; Korhonen et al., 2010; McGee, Williams, Poulton, & Moffitt, 2000; 
Mills, Kisely, Alati, Strathearn, & Najman, 2016).  Patterns of predictive factors may differ in 
US populations relative to other international settings due to the differences in cannabis policy 
environments. 
In terms of demographics, the literature on race/ethnicity correlates among cannabis users 
is heterogeneous. Among one sample of young adults, identifying as American Indian/Alaskan 
Native was positively associated with past year cannabis use (R. M. Johnson et al., 2015); 
however, other evidence suggested that cannabis users are more likely to identify as White (Bell, 
Wechsler, & Johnston, 1997; R. M. Johnson et al., 2016; Kaynak et al., 2013) or Asian (R. M. 
Johnson et al., 2016). For gender, the literature is more consistent with cannabis use being 
strongly associated with identifying as a male (Bell et al., 1997; Coffey, Lynskey, Wolfe, & 
Patton, 2000; R. M. Johnson et al., 2016; D. C. Lee et al., 2016). More recent work suggests that 
demographic correlates may differ based on method of cannabis use. In one examination, blunt-
only users were more likely to be African American compared to non-blunt cannabis users (A. 
Cohn, Johnson, Ehlke, & Villanti, 2016). Men are also more likely to use cannabis with a 
vaporizer (Jones et al., 2016; D. C. Lee et al., 2016; Morean et al., 2015) which is consistent with 
data from tobacco literature regarding electronic cigarette use (McMillen, Gottlieb, Shaefer, 
Winickoff, & Klein, 2015; Schoenborn & Gindi, 2015). These data support inquiry into 
understanding the demographic profiles of cannabis users by consumption method endorsed.  
 Harm perceptions regarding cannabis is another class of factors that has strong 
associations with use. Among a nationally representative sample of US adults in 2012 and 2014, 
approximately 29% perceived a great risk of harm from monthly cannabis use (A. Hughes, 
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Lipari, & Williams, 2016). Areas of the country with highest levels of use were more likely to 
perceive lower risks of harm from monthly cannabis use (A. Hughes et al., 2016). Among a 
sample of 725 US young adults in 2007, non-cannabis users reported higher risk of future 
academic consequences compared to cannabis users (71% vs. 20%; Kilmer, Hunt, Lee, & 
Neighbors, 2007). In the same study, non-cannabis users also perceived higher risk of social 
consequences compared to cannabis users (55% vs. 9%; Kilmer et al., 2007). Among a sample of 
young adults in Australia in 2006, lifetime cannabis users perceived cannabis as less risky 
compared to participants who had never used cannabis (O'Callaghan, Reid, & Copeland, 2006). 
Lifetime cannabis users’ perceived risk was lower on six dimensions: feeling sick after using, 
using other drugs, having accidents while under the influence of cannabis, legal consequences, 
physical health, and dependence problems (O'Callaghan et al., 2006). These data indicate that 
perceptions of lower health, social, and academic risks of cannabis use are associated with 
cannabis use.  
A range of other risky behaviors are also associated with cannabis use. Early initiation of 
cigarette smoking (at age 12 or earlier) is highly predictive of subsequent cannabis use during 
adolescence (Korhonen et al., 2010). Tobacco and alcohol use also predict cannabis use and 
dependence in young adulthood (Coffey et al., 2000; Mills et al., 2016). Alcohol, nicotine, and 
cannabis dependence at age 18 are predictors of past-year cannabis use among young adults 
(Haug et al., 2014; McGee et al., 2000). Cannabis use is also associated with other illicit drug use 
(Secades-Villa, Garcia-Rodriguez, Jin, Wang, & Blanco, 2015). A study using the Domain-
Specific Risk-Taking scale found that young adult cannabis users were more likely to exhibit 
social (e.g., disagreeing with a friend), health/safety (e.g., engaging in unprotected sex), and 
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ethical risks (e.g., stealing) compared to non-cannabis users (Gilman, Calderon, Curran, & Evins, 
2015). Indices of high impulsivity/sensation seeking also are predictive of past year cannabis use 
and cannabis dependence in young adulthood (Haug et al., 2014; Kaynak et al., 2013; McGee et 
al., 2000). As indicated, engagement in other risky behaviors including alcohol and tobacco use, 
along with certain race/ethnicity, gender, and harm perception profiles are predictive of general 
cannabis use. Further, some literature indicates there are differential patterns of predictors and 
correlates depending on methods of cannabis use.  
Few studies have investigated predictors or correlates of alternative forms of cannabis 
consumption such as vaporizer, concentrate, edible, and blunt use. Among those available, 
predictors of vaporizer use are cannabis initiation at a young age (D. C. Lee et al., 2016), more 
frequent (daily) cannabis use (D. C. Lee et al., 2016), high socioeconomic status (Jones et al., 
2016), higher perceived health (D. C. Lee et al., 2016), lifetime cigarette use (Morean et al., 
2015), and using a vaporizer for nicotine products (Jones et al., 2016; D. C. Lee et al., 2016). 
Among one large online sample of cannabis users in the US, ever cannabis vaporizer users 
indicated positive perceptions of vaping cannabis in terms of “health,” “taste,” “high,” and 
“satisfaction” (D. C. Lee et al., 2016). One qualitative study published in 2016 showed that 
among US youth aged 15-17, users who preferred edibles were more likely to endorse concerns 
about smoking cannabis (Friese, Slater, Annechino, & Battle, 2016). Interestingly, edible users in 
this sample also cited specific risks associated with edible use including edible-induced deaths, 
risks of the intense edible “high,” and unclear strength/content of edible products. This same 
study suggested that edible use was perceived as more prevalent among females and more 
accepted by females due to lack of smell or lower risk of discovery by adults (Friese et al., 
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2016). One study examined correlates of blunt use and non-blunt cannabis use among US adults 
using data from the 2013 NSDUH (A. Cohn et al., 2016). Results indicated blunt users and non-
blunt cannabis users had similar associations (more likely to be Black, young, male, and used 
other substances in the past month; however, non-blunt cannabis users had weaker associations 
with these variables than blunt users.   
Predictors and correlates of endorsing multiple consumption cannabis methods (i.e., poly-
use) or particular patterns of cannabis use (i.e., vaporizers and rigs or vaporizers-only) have not 
been examined extensively in the literature.  This lack of knowledge in combination with rapidly 
changing device types and technology all challenge the categorization and understanding of 
cannabis users and patterns of use. Importantly, there are statistical techniques that are optimized 
for identifying latent sub-groups of populations, which may be best suited for addressing this 
challenge. 
Methods to Understand Patterns and Correlates of Cannabis Consumption: Latent Class 
Analysis  
Among many statistical techniques used to understand drug-taking behavior, latent class 
analysis (LCA) has emerged as an advantageous person-centered approach to classify patterns of 
substance use (Evans-Polce, Lanza, & Maggs, 2016; Haardorfer et al., 2016; Harrell, Naqvi, 
Plunk, Ji, & Martins, 2016; Nasim, Blank, Cobb, & Eissenberg, 2012; Nasim et al., 2016; Tzilos, 
Reddy, Caviness, Anderson, & Stein, 2016). LCA groups individuals into “latent” (i.e., 
unobserved) classes based on their patterns of responding on indicator variables (i.e., selected 
variables relevant to the research question of interest; McCutcheon, 1987). LCA has been used 
among adolescent (Harrell et al., 2016; Nasim et al., 2012) and young adult populations (Evans-
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Polce et al., 2016; Haardorfer et al., 2016; Nasim et al., 2016; Tzilos et al., 2016) to understand 
patterns of tobacco use, cannabis/alcohol, as well as other illicit substances (Haardorfer et al., 
2016). One advantage is the use of LCA in combination with more traditional regression 
analyses to examine correlates of class membership. This combination of statistical techniques 
allows for the exploration of the differential characteristics of sub-groups identified (Pearson, 
Bravo, Conner, & Marijuana Outcomes Study, 2017).   
LCA can be used to examine latent patterns of substance use behavior among specific 
drug classes such as tobacco products. A national sample of US adolescent cigarette smokers 
was categorized using indicator variables that included measures of cigarette smoking frequency 
and intensity, lifetime smoking status, smoking persistence, and past 30-day alternative tobacco 
use (smokeless tobacco, cigars, bidi, clove cigarettes; Nasim et al., 2012). Each of the six latent 
classes predicted by the model (class membership prevalence ranged from 55-33%) was defined 
by unique patterns of cigarette and alternative tobacco product use: Class 1 (non-daily, light 
smokers), Class 2 (light smokers), Class 3 (light smokers who use alternative tobacco products), 
Class 4 (intermittent smokers), Class 5 (daily smokers), and Class 6 (daily smokers who use 
alternative tobacco products). Multinomial regression was used to examine demographic and 
other smoking-related covariates (i.e., nicotine dependence) that differed between classes. 
Findings suggested that smokers who engaged in alternative tobacco product use (Classes 3 and 
6) exhibited higher nicotine dependence symptomology, consistent with a greater risk profile. 
These data highlighted the variability in tobacco product consumption among youth and the 
importance of alternative tobacco product assessment and inclusion in tobacco prevention 
interventions.  
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LCA has also been used to understand latent poly-substance use patterns. In a large 
regional sample of US college students, indicators were selected to capture tobacco use 
prevalence (frequency of past 4-month and past 30-day use for cigarettes, little cigars/cigarillos, 
smokeless tobacco, e-cigarettes, and hookah), cannabis use, and alcohol use (Haardorfer et al., 
2016). Two sets of LCA models were developed to divide individuals into classes based on their 
substance use over the past 4 months and past 30 days. Both LCA models resulted in five distinct 
classes with differing class membership rates: Class 1 (abstainers), Class 2 (alcohol-only), Class 
3 (light poly-tobacco users), Class 4 (heavy poly-tobacco users), and Class 5 (little 
cigar/cigarillo-hookah-marijuana co-users; Haardorfer et al., 2016). Multinomial regression 
analyses were used to identify demographic, perception-related, and social factor correlates that 
differed by class membership. Findings revealed important variations in these associations (e.g., 
light poly-tobacco users were more likely to have parents that used tobacco but less likely to 
have friends who used tobacco) that were informative for prevention efforts.  
LCA may be particularly useful for identifying sub-groups of cannabis users that differ 
by cannabis use behaviors. Available data indicate that cannabis users, as a whole, have lower 
harm perceptions (A. Hughes et al., 2016; Kilmer et al., 2007; O'Callaghan et al., 2006) and 
exhibit risky behaviors (Badiani et al., 2015; Gilman et al., 2015; Secades-Villa et al., 2015) but 
also are characterized by heterogeneous use patterns (Hindocha et al., 2016; Loflin & 
Earleywine, 2014; Schauer, King, et al., 2016). Therefore, there may be sub-groups within the 
larger population of cannabis users which may be best elucidated using LCA techniques. 
Considering the rapid evolution of cannabis consumption methods and US state-level polices 
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regarding medicinal and recreational use, this information gap will be critical to assess in terms 
of understanding the changing population of cannabis users in the US.  
History of Cannabis Policy in the US 
Like many drugs, cannabis and policy regarding its use has experienced dramatic shifts in 
political and public opinion since its introduction to modern society. The first record of cannabis 
use was for medicinal purposes by the ancient Chinese in 2700 BC (M. A. Lee, 2012). 
Originally, cannabis was used in medicinal teas as a remedy for a variety of ailments including 
gout, malaria, and constipation. In the 1800s, cannabis was still widely used to treat ailments (M. 
A. Lee, 2012). By the late 1800’s oral ingestion methods were widely switched to smoking 
(combustion-based; M. A. Lee, 2012). By the 1930s, 24 US states had banned cannabis. 
In 1937, the first US law that indirectly banned the production, possession, and usage of 
cannabis, The Marihuana Tax Act, was passed and created a soaring tax on cannabis (M. A. Lee, 
2012). By this time, cannabis use had decreased for medicinal purposes and been replaced with 
modern-age medicines like aspirin. However, recreational cannabis use still continued (M. A. 
Lee, 2012). In the 1950s, the US federal government prioritized the restriction of drug use with 
the Boggs Amendment in 1951 and the Narcotics Control Act of 1956, which both increased 
penalties for violating drug laws including those regarding cannabis.  
In 1970, the Marihuana Tax Act of 1937 was deemed unconstitutional and was replaced 
by the Controlled Substances Act (CSA; M. A. Lee, 2012). The CSA, initially passed in 1970, 
was intended by the US Congress to further regulate cannabis and other substances by addressing 
multiple points including the manufacture, possession, and distribution of substances (FDA, 
2009). Since 1970, nine amendments to the CSA have been passed to further regulate other drugs 
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of abuse (e.g., steroids and psychotropic drugs), chemical precursors, and structurally similar 
drugs (FDA, 2009). The CSA also created a five-tiered classification system to rank the 
“potential for abuse” for each substance. According to the CSA, Schedule I substances have a 
high potential for abuse, no medical uses, and are not safe to use under medical supervision, 
while Schedule V substances have a low potential for abuse. The classification system 
categorizes natural cannabis as a Schedule I drug in the US; although synthetic forms of THC 
(i.e., dronabinol) are classified as Schedule III. The federal penalty for a first offense with 
possession of cannabis is a fine no less than $1,000 and up to 1 year in prison (Yeh, 2015). 
However, these penalties vary by state. States with decriminalized laws have minor penalties 
while other states with strict cannabis laws have major penalties (up to the federal level).  
Although cannabis remains illegal on a federal level, many states have opted to create 
new laws regarding cannabis. In 1996, California was the first state to legalize cannabis for 
medicinal purposes (Hanson, 2016). During the next twenty years, 28 more states and 
Washington, DC followed California’s lead to legalize cannabis medicinally (Hanson, 2016). 
Although medicinal cannabis laws between states are heterogeneous; generally, the laws legally 
constitute the possession of a certain amount of cannabis and the cultivation of a specific number 
of plants only if the consumer has a medical condition that allows for the use of cannabis (see 
Table 3 for a summary by state). In 2012, Colorado became the first state to legalize both 
recreational and medicinal cannabis, followed by Washington one month later. Both Oregon and 
Alaska legalized cannabis for recreational and medicinal purposes in 2014. In 2016, California, 
Maine, Massachusetts, and Nevada legalized recreational cannabis (NPR, 2016). Recreational 
cannabis laws vary across states by possession amount, number of plants allowed for cultivation,  
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Table 3. US States with Legalized Medical and/or Recreational Cannabis Laws 
US State Cannabis 
products 
available for 
medical use 
Cannabis products 
available for 
recreational use 
Recreational use policy details 
(Ballotpedia, 2016; NORML, 2016) 
Alaska Yes Yes 1 oz. possession & grow 6 plants 
Arizona Yes No -- 
Arkansas Yes No -- 
California Yes Yes 1 oz. possession, grow 6 plants, & 8 
g concentrate possession 
Colorado Yes Yes 1 oz. possession, grow 6 plants, & 1 
oz. concentrates 
Connecticut Yes No -- 
Delaware Yes No -- 
Washington, DC Yes Yes 2 oz. possession & grow 6 plants 
Florida Yes No -- 
Hawaii Yes No -- 
Illinois Yes No -- 
Louisiana Yes No -- 
Maine Yes  Yes 2.5 oz. possession & grow 6 plants 
Maryland Yes No -- 
Massachusetts Yes Yes 1 oz. possession & grow 6 plants 
Michigan Yes No -- 
Minnesota Yes No -- 
Montana Yes No -- 
Nevada Yes Yes 1 oz. possession, grow 6 plants, & 
1/8th oz. concentrates 
New Hampshire Yes No -- 
New Jersey Yes No -- 
New Mexico Yes No -- 
New York Yes No -- 
North Dakota Yes No -- 
Ohio Yes No -- 
Oregon Yes Yes 1 oz. possession, grow 4 plants, 72 
oz. of liquid concentrates, 16 oz. of 
solid concentrates, & 1 oz. of 
concentrate extract 
Pennsylvania Yes No -- 
Rhode Island Yes No -- 
Vermont Yes No -- 
Washington Yes Yes 1 oz possession, 72 oz. of liquid 
concentrates, 16 oz. of solid 
concentrates, & 7 g of concentrate 
extract.  
Note. Cannabis products include dried plant material.  
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and the legality of concentrates; however, all recreational cannabis users must be 21 years of age 
(see Table 3). Importantly, although many states and territories have relatively ignored the 
stipulations of the CSA, cannabis is still considered federally illegal in the US. These changes in 
cannabis policy warrant investigation in order to reduce the potential harms of cannabis 
legalization on youth and young adults (Choo & Emery, 2016; Dirisu, Shickle, & Elsey, 2016). 
Methods to Evaluate Cannabis Policy Change 
Measures of trends in drug use are among the most common means to measure the effects 
of policy changes. One study, conducted between 1991 and 2001, paired states with and without 
medical cannabis laws and compared past month adolescent cannabis use rates (Choo et al., 
2014). No significant differences were found in adolescent cannabis use between states with and 
without medical cannabis laws (Choo et al., 2014). However, another more recent study 
conducted between 2002 and 2011 using data from NSDUH determined that adolescent cannabis 
use rose after the implementation of medical cannabis laws (Stolzenberg, D'Alessio, & Dariano, 
2016). Results from another study that examined the effects of international drug policies in a 
sample of over 170,0000 adolescents in 38 countries across three time points (2001-2010) 
determined that adolescents were more likely to report lifetime, past year, and regular cannabis 
use in legalized policy environments relative to an illegalized policy environment (Shi, Lenzi, & 
An, 2015). A study using longitudinal data in 1991-2011 from the YRBS examined the influence 
of medical cannabis laws on cannabis use among adolescents (J. Johnson, Hodgkin, & Harris, 
2017). After controlling for state, year, and demographic variables, data indicated that although 
cannabis use was higher in states with medical cannabis laws, there was no increase in past 30-
  
29 
 
day cannabis use or past 30-day heavy cannabis use due to policy changes in states with medical 
cannabis laws (J. Johnson et al., 2017). Therefore, researchers indicated that the difference in 
cannabis use patterns was likely due to differential social norms in each state, not medical 
cannabis laws (J. Johnson et al., 2017). These data illustrate the utility of prospectively 
monitoring changes in drug use before and after a policy is implemented as well as collecting 
other measures (i.e., social norm indices) that may be associated with changes in drug use.   
There is strong evidence that effects of drug policy on drug use behavior may be 
influenced by harm perceptions and social norms (L. D. Johnston, O'Malley, Miech, Bachman, & 
Schulenberg, 2016). The MTF study examines 12th graders’ perceived risk, disapproval, and 
availability of cannabis as well as cannabis use behavior over time (L. D. Johnston et al., 2016). 
Between the 1970s and 1990s, perceived risk of cannabis decreased while cannabis use increased 
(L. D. Johnston et al., 2016). This trend suggests that increasing perceived risk may reduce rates 
of cannabis use, but more recent data highlights the complex interplay of these factors. From 
2005 to 2015, the percentage of 12th graders who reported a “great risk” in regular cannabis use 
declined from 58% to 32% without a corresponding increase in cannabis use (L. D. Johnston et 
al., 2016). Other data from the NSDUH indicated that the relationship between harm perceptions 
and cannabis use patterns among people aged 12 and older (i.e., lower perceived harm coupled 
with lower use) was still evident from 2012 to 2014 (A. Hughes et al., 2016). This decline in 
perceived risk among both youth and adult populations could be the result of cannabis policy 
changes throughout the US. Cannabis was prohibited originally in the US due to its purported 
increased harm potential to users. Due to the relaxation of medical and recreational cannabis 
laws, youth now may interpret that cannabis is safe to use (Dirisu et al., 2016). Data from the 
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MTF study also indicated that although personal disapproval of regular cannabis use in 2015 
remained high for 12th graders (71%), this rate of disapproval had decreased since 2007 (83%). 
In addition, the percentage of 12th graders who reported that cannabis is “fairly easy” or “very 
easy” to obtain has remained between 80% and 90% since the beginning of the MTF study in 
1975. In 2015, approximately 80% of 12th graders reported that cannabis was easily attainable. 
Decreases in perceived risk and disapproval of cannabis use and increases in access to cannabis 
in response to cannabis policy changes could contribute to future changes in cannabis use 
patterns (L. D. Johnston et al., 2016).  
Although useful, measuring drug use patterns and associated factors like harm 
perceptions and disapproval before and after a policy change is not always viable (such as the 
case of a future or proposed policy change). In addition, pre-post designs cannot be used to 
examine unintended effects prior to policy implementation or when developing cannabis policies 
that have not been implemented in other environments. For example, pre-post studies do not 
illustrate what effects would occur following legalization of cannabis in a state with long-
standing restrictions on medical and recreational use (e.g., Virginia or Wisconsin). While these 
environments may share some similarities to other US states where cannabis legalization policy 
has been implemented (e.g., Colorado or Washington), important geographical and population 
differences may result in differential outcomes and risks to certain populations like youth or 
young adults.  
Simulation modeling provides one option to help predict the impact of future or 
hypothetical health policies, but this approach typically requires longitudinal data sources as 
a foundation (Cobb et al., 2015; Levy, Bauer, & Lee, 2006; Levy et al., 2011). Choice 
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experiments, which are primarily used in economics literature, could also be used to evaluate 
potential policy changes; however, these methods incorporate a price or “willingness to pay” 
framework which would add a price dynamic into the study. Prices for cannabis tend to fluctuate 
depending on the state, the specific laws in that state or locality, and the time of year. Choice 
experiments would add a price confound into the methods (Barnes et al., 2013; Ginon, Chabanet, 
Combris, & Issanchou, 2014; Olesen, Alfnes, Bensze Røra, & Kolstad, 2010). Importantly, the 
use of experimental and cross-sectional designs, often driven by behavior change theories, can 
provide an additional alternative to understand the impact of potential policy changes related to 
health behaviors (Darmon, Lacroix, Muller, & Ruffieux, 2014; Epstein et al., 2015; Pesko, 
Kenkel, Wang, & Hughes, 2016; Wackowski, Manderski, & Delnevo, 2014). These types of 
studies typically compare alterations of a policy environment relative to the "status quo" or 
current policy environment to determine the hypothetical impact on outcomes of interest 
including intentions to use a drug (e.g.., tobacco, cannabis) or engage in a behavior (e.g., 
purchase food/calories). Many studies have shown a consistent relationship between intentions to 
use cannabis and the actual use of cannabis (D'Amico, Miles, & Tucker, 2015; L. D. Johnston et 
al., 2016; Kilmer et al., 2007; Lopez-Quintero & Neumark, 2010). Using intentions as a primary 
outcome is supported by several theories of behavior change including the Theory of Planned 
Behavior (Ajzen, 1991).   
As described above, methods to evaluate cannabis policy change are dominated by long-
term longitudinal approaches that measure cannabis use behavior and proximal outcomes such as 
cannabis harm perceptions, disapproval rates, and availability perceptions. In the absence of such 
data or to address questions regarding the potential effects of new or hypothetical cannabis 
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policy in untested environments, alternative methods must be considered. Experimental designs 
using a behavior change theory approach provide one such option.  
Predicting cannabis use: The Theory of Planned Behavior. The Theory of Planned 
Behavior (TPB) is a suitable framework for assessing cannabis use and the antecedents of use 
(Ajzen, 1991; Conner & McMillan, 1999). The TPB reveals motivations and beliefs about a 
behavior (Glanz, 2015). The TPB incorporates three main factors that influence intentions to act 
on a behavior and consequently, the behavior itself (Ajzen, 1991). The three factors that 
influence intentions are 1) attitudes about the behavior, 2) subjective norms, and 3) perceived 
behavioral control. Attitudes are positive or negative beliefs about a behavior. Subjective norms 
are the perceived pressures to perform a behavior. Two distinct categories fall under subjective 
norms: injunctive/normative and descriptive norms. Injunctive norms are the pressures one feels 
from others to engage in a behavior (i.e., “do others think you should use cannabis?”). 
Descriptive norms are perceived beliefs about the engagement of others in the behavior (i.e., “do 
you think other people use cannabis?”). Perceived behavioral control is how easy or difficult it is 
for one to perform the behavior. Self-efficacy is the belief one has in their ability to complete a 
behavior. These three components – attitudes, subjective norms, and perceived behavioral 
control – contribute to intentions to perform a behavior. Ajzen postulated that intentions to 
perform a behavior is the closest antecedent to actual behavior performance (1991). A 
hypothetical cannabis policy environment may influence attitudes, subjective norms, and 
perceived behavioral control, as well as intentions to perform a behavior.  
 Due to the hypothetical nature of evaluating changes in a not-yet implemented cannabis 
policy environment, it is challenging to measure actual behavior performed. Therefore, 
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examining intentions to perform a behavior, in this case, intention to use cannabis, as well as 
associated influential factors (attitudes, subjective norms, and perceived behavioral control) 
provide the optimal tools in which to test the impact of a future cannabis policy change within an 
existing policy environment.  
Statement of the Problem 
Cannabis is a drug class that can be used in a variety of ways through different types of 
administration with little data available regarding patterns and profiles of cannabis use by 
consumption method. This information may have important implications for understanding 
cannabis user populations and informing cannabis prevention and intervention efforts. The US 
cannabis policy environment is rapidly changing with many states legalizing cannabis for 
medicinal use and several states legalizing recreational cannabis despite the US federal 
government’s illegal stance on cannabis. These changes may affect the methods in which 
cannabis is consumed and the types of individuals who consume cannabis. Understanding the 
influence of cannabis policy changes (i.e., increased legalization) is needed particularly for 
unique and untested environments that may respond differentially compared to those where 
cannabis policy has already been implemented and/or longitudinal data is available. Assessment 
of these policy-related outcomes using an experimentally-based design can inform regulators and 
potentially limit the harms of future cannabis policy on at-risk populations such as young adults.  
The Present Study 
 This study has three primary aims: 1) to assess what methods and patterns of cannabis 
consumption are most prevalent among young adults using an LCA approach, 2) to test whether 
certain patterns of cannabis use are associated with differential demographics, harm perceptions, 
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and risk taking behaviors, and 3) to determine if hypothetical cannabis policy environments 
(legal-policy vs. medical-policy vs. illegal-policy) influence attitudes, injunctive norms, 
perceived behavioral control, and intentions to use cannabis among a young adult population.  
 Hypothesis 1: The largest latent classes of young adult cannabis users will involve 
combustion-based methods of cannabis use (i.e., joints, blunts, bongs, and bowls). Evidence 
from adolescent populations indicates combusted methods are most prevalent (D. C. Lee et al., 
2016). We expect that users may engage in multiple methods of cannabis consumption, but 
combustion-based consumption or a combination of combustion-based methods will be most 
frequent.  
 Hypothesis 2: Latent classes composed of primarily combusted cannabis users will 
significantly differ in their demographics, harm perceptions, and risk-taking behaviors from user 
classes who primarily use non-combusted forms of cannabis. Combusted cannabis users will 
more likely be male, White/Caucasian, have lower harm perceptions about cannabis, and have 
greater risk-taking behaviors relative to those who use non-combusted forms of cannabis.  
 Hypothesis 3: The legal-policy condition will elicit the highest intentions to use, 
followed by the medical-policy condition and the illegal-policy condition. Self-reported attitudes 
towards cannabis will be highest (i.e., more favorable) in the legal-policy condition and lowest in 
the illegal-policy condition. Injunctive norms regarding cannabis will be highest in the legal-
policy condition followed by the medical-policy condition and the illegal-policy condition. 
Measures of perceived behavioral control and self-efficacy to use cannabis will be highest in the 
legal-policy condition and lowest in the illegal-policy condition.   
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Method 
Selection of Participants 
Approximately 1,500 students from a large (30,000 students) urban university in a Mid-
Atlantic US city were potentially eligible to participate in this online cross-sectional survey study 
based on course enrollment. Eligibility criteria to participate were undergraduate student status, 
at least 18 years of age, and enrolled in a course where research credit could be earned to satisfy 
course requirements. Between February 2017 and May 2017, 543 participants enrolled in this 
study. Of the total participants enrolled, 86 were excluded from analyses due to failure to meet 
inclusion criteria (n = 3), failing to complete any of the survey beyond consent (n = 24), failing 
the attention check (n = 18), failing to finish the survey in its entirety (n = 40), and illogical 
responding (n = 1). The final sample consisted of 457 participants of which 208 (45.5%) met 
criteria for analysis for Hypothesis 1 (past month cannabis use), 204 (45.5%) met criteria for 
analysis for Hypothesis 2, and 446 (97.6%) met criteria for analysis for Hypothesis 3.  
The enrolled sample met the proposed sample projection of approximately 500 
participants which was based on preliminary data from two similarly designed studies of 
undergraduate students at the same institution performed in Spring 2016 and Fall 2016.  These 
two previous studies estimated past 30-day cannabis use was between 30-50% (personal 
communication with C. Cobb) resulting in an analytic sample for the LCA (Hypothesis 1) 
between 150-250 individuals (meeting minimum sample size for LCA which ranges from 100-
500; Collins & Wugalter, 1992; Finch & Bronk, 2011; Wurpts & Geiser, 2014). The projected 
sample size for the LCA was expected to at least allow for logistic regression analyses to 
examine differences in demographics, harm perceptions, and risk behaviors between the two 
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largest classes identified. For Hypothesis 3, the entire sample (N ≈ 500) was planned to be 
utilized, and a power analysis aimed to detect a small to medium effect size of f = 0.25 (α = 0.05, 
with at least 6 covariates; power = 0.95) for an analysis of covariance (ANCOVA) determined a 
minimum sample size of 210 participants (GPower 3.1.9.2). The current study protocol and all 
associated measures were approved by the Virginia Commonwealth University’s Institutional 
Review Board.   
Procedures 
The study design was cross-sectional and used only self-report measures, which was 
executed completely online. Interested individuals reviewed study information via an online 
study system developed specifically for administering undergraduate research studies (SONA, 
https://vcu.sona-systems.com). If interested in a particular study, participants “signed up” to gain 
access to the study-specific weblink. After clicking on the weblink, participants were routed 
outside of the study system to a secure webpage that hosted the experimental survey 
(administered via Qualtrics). After reviewing a brief description of the study and expected 
involvement, participants clicked yes to agree to continue and then confirmed eligibility status 
(age ≥18 years old and undergraduate student status). Participants who did not meet eligibility 
requirements were excluded from participation. Following eligibility confirmation, the survey 
consisted of baseline measures asked of all participants (see Measures below) followed by 
randomization to one of three hypothetical cannabis policy conditions: legal-policy, medical-
policy, or illegal-policy (see Cannabis Policy Conditions below). At the conclusion of the 
survey, participants were directed to click a weblink which directed them to a separate survey 
webpage to leave their name and contact information for crediting purposes (0.5 credits per 
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person). This practice ensured the survey data were not directly linked with individuals’ 
identifying information. Individuals who did not reach this point in the survey were instructed to 
email the survey administrators directly to obtain partial credit (0.20 credits).  
Measures 
All participants completed a survey that consisted of baseline demographic measures, 
cannabis, alcohol, and tobacco use patterns, tobacco and cannabis harm perceptions, risk-taking 
behaviors, and baseline intentions to use cannabis followed by randomization to one of three 
hypothetical cannabis policy conditions (legal-policy, medical-policy, or illegal-policy) where 
cannabis attitudes, descriptive norms, injunctive norms, perceived behavioral control, self-
efficacy, and intentions to use were assessed. One question was included as an attention check, 
and participants who completed an answer to the attention check were excluded from analysis (n 
= 18).   
Cannabis Policy Conditions. After completing baseline measures, participants were 
randomly assigned automatically to one of three hypothetical cannabis policy conditions (legal-
policy, medical-policy, or illegal-policy) where a condition-specific scenario was presented (See 
Table 4 and Appendix A). Participants were instructed to complete six measures within the 
context of the assigned hypothetical cannabis policy condition (i.e., attitudes, descriptive norms, 
injunctive norms, perceived behavioral control, self-efficacy, and behavioral intentions). In order 
to ensure participants recalled which policy condition to which they were randomized, a policy 
condition prompt was shown at the top of each measure (See Appendix B).
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Table 4. Cannabis Policy Conditions 
Item 
Description 
Legal Cannabis 
Policy Condition 
US State Policy 
Reference 
(Ballotpedia, 
2016; NORML, 
2016) 
Medical Cannabis 
Policy Condition 
US State Policy 
Reference 
Illegal Cannabis 
Policy Condition 
US State Policy 
Reference 
(Ballotpedia, 
2016; NORML, 
2016) 
Instructions The next several 
sections will ask 
you to answer the 
questions in the 
context of the 
situation stated 
below. Imagine 
you live in a state 
where marijuana 
is medically and 
recreationally 
LEGAL.  
NA The next several 
sections will ask 
you to answer the 
questions in the 
context of the 
situation stated 
below. Imagine 
you live in a state 
where marijuana 
is medically 
LEGAL 
NA The next several 
sections will ask 
you to answer the 
questions in the 
context of the 
situation stated 
below. Imagine 
you live in a state 
where marijuana 
is medically and 
recreationally 
ILLEGAL. 
NA 
       
Medical use Patients with 
written medical 
consent may 
possess up to two 
ounces of medical 
marijuana. 
Similar to 
Colorado, 
Washington, DC, 
New Hampshire, 
New Jersey, & 
Vermont  
NA NA Marijuana in any 
form may not be 
prescribed by any 
medical 
professional. 
 
All illegal 
cannabis states 
       
Age Use of marijuana 
is legal for anyone 
over the age of 21. 
All recreational 
cannabis laws 
Anyone with 
written medical 
consent may use 
marijuana for 
medical purposes. 
Similar to 
Arizona, Illinois, 
& Maine 
Use of marijuana 
is illegal for 
anyone of any 
age.  
All illegal 
cannabis states 
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Possession 
and 
cultivation 
Anyone over the 
age of 21 may 
possess up to 1 
ounce of retail 
marijuana and 
may grow up to 6 
marijuana plants. 
Similar to Alaska, 
California, & 
Colorado 
Anyone with 
written medical 
consent may 
possess up to 2.5 
ounces of medical 
marijuana. 
Growing 
marijuana of any 
amount may result 
in criminal 
prosecution and 
fines. 
Similar to 
Arizona, Illinois, 
& Maine 
Possession and 
growing of 
marijuana of any 
amount results in 
criminal 
prosecution and 
fines. 
All illegal 
cannabis states 
Purchase Purchase of up to 
one ounce of retail 
marijuana at a 
marijuana 
dispensary is legal 
for anyone 21 
years or older.  
Similar to Alaska, 
California, 
Colorado, & 
Oregon 
Anyone with 
written medical 
consent may 
purchase up to 2.5 
ounces of 
marijuana for 
medical purposes 
at a dispensary.  
Similar to 
Arizona, Illinois, 
& Maine 
Purchase of 
marijuana of any 
amount and from 
any source results 
in criminal 
prosecution and 
fines.  
All illegal 
cannabis states 
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Measures Administered Prior to Randomization. 
 Demographic Measures. Participants were asked to provide demographic information on 
age, gender, race/ethnicity, school level, year in college, grades in school, and current and past 
state of residency prior to college (Youth Risk Behavior Survey Questionnaire, 2015).  Gender 
categories included “man,” “woman,” and “other,” which was recoded to exclude “other” 
categories from all analyses due to low frequencies. Race/ethnicity categories included “White or 
European-American,” “Black, Afro-Caribbean, or African American,” “Asian American,” 
“American Indian or Alaska Native,” “Native Hawaiian or Other Pacific Islander,” “Middle 
Eastern or Arab American,” “Multiracial,” or “Other.” Participants were also asked “Do you 
consider yourself Hispanic/Latino(a)?” with response options “Yes” and “No.” If a respondent 
indicated that they considered themselves to be Hispanic/Latino, they were classified as only 
Hispanic/Latino, and this variable was collapsed into the race/ethnicity variable. Race/ethnicity 
was recoded to “White,” “Black,” “Asian,” “Hispanic/Latino,” and “Multiracial/Other” due to 
low frequencies. School level included the following categories: “high school graduate,” “GED 
or equivalent,” “some college/no degree,” “associate degree,” “bachelor’s degree,” “master’s 
degree,” and “professional or doctoral degree.” School level was recoded to “high school or 
GED,” “some college/no degree,” and “associate’s or bachelor’s degree” due to low frequencies. 
Year in college categories included “first year,” “second year,” “third year,” “fourth year,” and 
“fifth or more year.” School grades categories included “Mostly A’s,” “Mostly B’s,” “Mostly 
C’s,” “Mostly D’s,” “Mostly F’s,” “None of these grades,” and “Not Sure.” School grades were 
recoded to “Mostly A’s,” “Mostly B’s,” “Mostly C’s, D’s or F’s,” and “Not sure.” For these 
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analyses, respondents who reported “Not sure” for school grades were excluded. For current and 
past state of residency, a drop-down list of US states was provided.  
 Cannabis Use Patterns. Lifetime (yes/no), past 12-month (number of days), past 30-day 
(number of days), and past 30-day occasions (number of occasions) of cannabis were determined 
by adapting questions from the MTF questionnaire (L. Johnston, Miech, O'Malley, Bachman, & 
Schulenberg, 2015) and the NSDUH (CBHSQ, 2015). Among lifetime cannabis users, age of 
cannabis initiation, cannabis prescription status (yes/no), and methods of lifetime use were 
assessed; however, age of cannabis initiation was not used for analyses and will not be discussed 
further. Methods of cannabis administration used in their lifetime were determined by listing the 
following methods: “joint or spliff (marijuana cigarette with or without tobacco)” [joint], “blunt 
(cigar with marijuana with or without tobacco)” [blunt], “bowl or pipe that does not include 
water (glass of homemade pipe/apple pipe)” [bowl/pipe], “bong or water pipe (bucket/gravity)” 
[bong], “hot knife,” “rig (typically used with concentrates and a blowtorch or electric heat 
source)” [rig], “Vaporizer or other electronic device (Volcano or PAX) [vaporizer],” “edibles 
(brownies, teas, tinctures, sprays)” [edible],  or “some other way.” Lifetime use of types of 
cannabis were determined by the following options: “dried marijuana (bud, weed),” “butane hash 
oil (BHO), kief, shatter, wax, rosin, or another form of concentrate,” “cooked (tincture, spray, 
cannabutter),” or “some other way.” Lifetime methods of cannabis administration and lifetime 
use of types of cannabis were not used for analyses and will not be discussed further. Only users 
who reported using cannabis at least once in the past 12 months were asked about past 30-day 
use. Among past 30-day users, occasions and days of cannabis administration methods and 
cannabis types used were assessed (using same list of methods and types above). The frequency 
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of administration method and cannabis type used (number of occasions for each method and type 
endorsed) also was measured. Types of cannabis used in the past 30 days were not used in 
analyses; therefore, will not be discussed further. The past 30-day occasion frequency of joint, 
blunt, bowl/pipe, bong, and edible were recoded where 0 = 0 occasions, 1 = 1-10 occasions, and 
2 = 10 or more occasions. Past 30-day occasion frequency of vaporizer and rig were combined 
and recoded into a dichotomous item where 0 = 0 occasions and 1 = 1 or more occasions. The 
amount of cannabis used in the past 30 days (“Do you know how much marijuana you have used 
(in ounces) during the last month?”) was assessed; response options: “None,” “less than ½ 
ounce,” “about ½ ounce,” “about 1 ounce,” “about 2 ounces,” “3 to 5 ounces,” “6 or more 
ounces,” “6 or more ounces,” and include “Don’t know.” Current state of cannabis intoxication 
(yes/no) during the survey administration was assessed (Davis et al., 2014; Schauer, King, et al., 
2016) of all lifetime cannabis users. Preferred type of cannabis and preferred method of cannabis 
administration were also assessed. Amount of cannabis used in the past 30 days, current state of 
cannabis intoxication, preferred type of cannabis, and preferred method of cannabis 
administration were not included in analyses; therefore, they will not be discussed further.  
 Cannabis Dependence. Cannabis dependence was assessed using the Severity of 
Dependence Scale for cannabis users (van der Pol et al., 2013). The scale contains five items that 
determine the degree of cannabis dependence. All five items started with the same stem “During 
the past year…” The first four items were “… did you think your use of marijuana was out of 
control?” “…did the prospect of missing a dose of marijuana make you anxious or worried?” 
“…did you worry about your use of marijuana?” and “…did you wish you could stop the use of 
marijuana?” For the first four items, response options included “never/almost never (1),” 
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“sometimes (2),” “often (3),” and “always/nearly always (4).” The fifth item was “…how 
difficult did you find it to stop, or go without marijuana?” with response options as “not difficult 
(1),” “quite difficult (2),” “very difficult (3),” and “impossible (4).” Responses were totaled with 
a maximum score of 15.  
 Alcohol Use Patterns. Lifetime (yes/no) alcohol use was determined by adapting 
questions from the NSDUH (CBHSQ, 2015). The item asked, “Have you ever, even once, had a 
drink of any type of alcoholic beverage?” 
 Tobacco Use Patterns and Tobacco Dependence. Lifetime and 30-day use (number of 
days) of tobacco products were included “Cigarettes,” “Traditional cigars (Macanudo, Romeo y 
Julieta, or Arturo Fuente),” “Pipe (with tobacco),” “Little cigars/cigarillos (like Black & Milds, 
Swisher Sweets, or Phillies Blunt),” “E-cigarettes (like BLU or NJOY),” “Chewing tobacco (like 
Levi Garrett, Red Man, or Beech Nut),” “Dip/snuff (like Skoal or Copenhagen),” “Snus (like 
Camel Snus),” “Dissolvable tobacco products (like Ariva, Stonewall, Camel Orbs, Sticks or 
Strips),” “Hookah/shisha (hookah tobacco),” and “Nicotine replacement products (like gum, 
patches, lozenges)” (A. M. Cohn, Johnson, Rath, & Villanti, 2016; Rath et al., 2016). Past 30-
day tobacco use by product was dichotomized to “yes” or “no.” The first type of tobacco product 
ever used and the age of tobacco initiation were assessed, but were not used in the current 
analyses, as well as lifetime tobacco use; therefore, these variables will not be discussed further. 
Fagerström Test for Nicotine Dependence was also assessed, but was not used for the current 
analyses and will not be discussed further (Heatherton, Kozlowski, Frecker, & Fagerstrom, 
1991). 
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 Baseline Cannabis Behavioral Intention. This scale, adapted from the marijuana 
behavioral intention scale (Armitage, Armitage, Conner, Loach, & Willetts, 1999), consists of 
three items: “I intend to use cannabis/marijuana,” “I plan to use cannabis/marijuana,” and “I 
want to use cannabis/marijuana.” Responses range from (1) “Definitely do not” to (7) “Definitely 
do” (α = 0.98). Responses were totaled, and the maximum score was 21.  
 Harm Perceptions. Harm perceptions were determined by asking “How harmful do you 
think that the following products are to your health?” (α = 0.94). Responses ranged from (1) 
“Extremely harmful” to (7) “Not harmful at all” and included (8) “Don’t know.” Harm 
perceptions were determined for the following items: “tobacco cigarettes,” “smokeless tobacco,” 
“electronic cigarettes,” “hookah/shisha,” “little cigars/cigarillos,” “marijuana used in a joint or 
spliff,” “marijuana used in a blunt,” “marijuana used in a bowl or pipe that does not include 
water,” “marijuana used in a bong or waterpipe,” “marijuana used with a hot knife,” “marijuana 
used with a rig,”  “marijuana used with a vaporizer or other electronic device,” and “marijuana in 
an edible form.” Tobacco-product harm perceptions were not used in the current analysis; 
therefore, they were excluded. Cannabis-product harm perceptions were averaged across 
cannabis products assessed excluding “marijuana used with a hot knife” and “marijuana used 
with a rig” due to a high proportion of cases that responded “don’t know.” Cases that responded 
“don’t know” to any cannabis harm perception item were also excluded.  
 Brief Sensation Seeking Scale. Sensation seeking was measured with the Brief Sensation 
Seeking Scale (BSSS; α = 0.75; Hoyle, 2002). This scale contains eight items and measures the 
amount to which one agrees or disagrees with engaging in risky activities (e.g., “I like to do 
frightening things” and “I would like to try bungee jumping”). Responses range from (1) 
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“Strongly disagree” to (5) “Strongly agree.” The scale was recoded by averaging scores across 
items (Hoyle, 2002). 
Measures Administered Post-Randomization. 
 Attitudes. Attitudes in the framework of the TPB are beliefs about a behavior. Attitudes 
also capture the degree to which a person positively or negatively values a behavior (α = 0.97; 
(Glanz, 2015). Attitudes about cannabis use were measured using an adapted 7-point bipolar 
scale (Armitage et al., 1999). The scale includes four items, which begin with the same stem 
“My using cannabis would be…” Responses range from (1) “bad, unfavorable, negative, 
unsatisfactory” to (7) “good, favorable, positive, satisfactory” and were totaled for a maximum 
score of 28.  
 Descriptive Norms. Descriptive norms are perceptions about others’ behavioral patterns 
(α = 0.74; (Glanz, 2015). For the present study, two adapted items were used for measuring 
perceptions of prevalence of cannabis use (e.g. “Most people my age have tried 
cannabis/marijuana,” “Most people my age smoke cannabis/marijuana regularly”;  (Ito, Henry, 
Cordova, & Bryan, 2015). Responses range from (1) “Strongly disagree” to (7) “Strongly agree.” 
Descriptive norms were not used in data analysis.  
 Injunctive Norms. Injunctive norms are one’s perceptions of whether peers and other 
important people approve of the behavior. Injunctive norms were measured with three adapted 
items (α = 0.77; e.g. “My friends think I should use cannabis/marijuana,” “My parents think I 
should use cannabis/marijuana,” “People who are important to me think I should use 
cannabis/marijuana”; Ito et al., 2015). Responses range from (1) “Strongly disagree” to (7) 
“Strongly agree” and were totaled for a maximum score of 21.  
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 Attention Check. In order to avoid satisficing among participants, an attention check was 
included (e.g., “If you read this question, please leave the answer blank”). Responses range from 
(1) “Strongly disagree” to (7) “Strongly agree.” Participants who responded to this question were 
excluded from analyses (n = 18).  
 Perceived Behavioral Control. Perceived behavioral control is the amount of self-control 
one has over a behavior. Perceived behavioral control was measured with three items (α = 0.69; 
e.g., “Whether or not I use cannabis/marijuana is entirely up to me,” “How much personal 
control do you feel you have over using cannabis/marijuana?,” “How much do you feel that 
using cannabis/marijuana is beyond your control?”; Armitage et al., 1999). Responses range 
from (1) “Strongly agree, very little control, very much so” to (7) “Strongly disagree, complete 
control, not at all.” Responses were totaled for a maximum score of 21.  
 Self-Efficacy. Although similar to perceived behavioral control, self-efficacy is the 
perceived ability one has to perform a behavior. The self-efficacy measure consisted of four 
items: “I believe I would have the ability to use cannabis/marijuana” “To what extent do you see 
yourself as being capable of using cannabis/marijuana?” “How confident are you that you would 
be able to use cannabis/marijuana?” “If it were entirely up to me, I am confident that I would be 
able to use cannabis/marijuana” (α = 0.95; Armitage et al., 1999). Responses range from (1) 
“Definitely do not, very incapable of using cannabis/marijuana, very unsure, strongly disagree” 
to (7) “Definitely do, very capable of using cannabis/marijuana, very sure, strongly agree. 
Responses were totaled for a maximum score of 28.  
 Post-Randomization Behavioral Intention. This scale, adapted from the marijuana 
behavioral intention scale (α = 0.98; (Armitage et al., 1999), consisted of three items: “I intend to 
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use cannabis/marijuana,” “I plan to use cannabis/marijuana,” and “I want to use 
cannabis/marijuana.” Responses range from (1) “Definitely do not” to (7) “Definitely do.” 
Responses were totaled, and the maximum score was 21. 
Data Analysis 
Following data cleaning and recoding procedures described above, statistical analyses 
were conducted using IBM SPSS (Version 22), STATA (StataCorp, 2015), and Latent Gold 4.5 
(Statistical Innovations Inc., 2008). Overall sample descriptives were performed on the included 
sample as well as bivariate comparisons for demographic items between those that were 
excluded from primary analyses. 
Hypothesis 1 was analyzed using LCA with Latent Gold 4.5. First, individuals who 
endorsed using cannabis on at least one occasion in the past 30 days were selected (n = 208). 
Latent class indicator variables included frequency of past-month occasions used for six methods 
of cannabis consumption assessed: joint, blunt, bowl/pipe, bong, edible, and vaporizer/rig. 
Responses for vaporizer and rig use were combined due to low frequencies. The item assessing 
hot knife use was excluded from this analysis due to low use frequencies (n = 1) and the item 
assessing cannabis use “some other way” was recoded by hand wherein each item was assessed 
and combined with other methods of administration categories. An exploratory strategy was used 
to build the model, increasing the number of classes until a class solution that adequately fit the 
data was determined. Ten latent class models were estimated to identify underlying groups of 
cannabis users based on methods of cannabis administration. The Bayesian Information Criterion 
(BIC) and the Akaike Information Criterion (AIC) were used as global fit indices as well as 
consideration of parsimony (fewest number of parameters; Npar) and low likelihood of 
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classification error to determine the appropriate number of latent classes in the model (Evans-
Polce et al., 2016; Haardorfer et al., 2016; Nasim et al., 2016; Tzilos et al., 2016). The L2 statistic 
was also used to determine model fit. The L2 statistic specifies the associations that are 
unexplained in the model with lower L2 values indicating a better model fit. Additionally, in 
order to test more precisely for model fit, bootstrapping was used. Bootstrapping accounts for 
violations of the assumption that the L2 statistic has a chi square distribution (Vermunt & 
Magidson, 2005). 
Hypothesis 2 could not be analyzed as planned. Due to low frequencies in the 4-class 
model from the LCA, there was insufficient power to conduct regression analyses even between 
the two largest classes; therefore, descriptive and bivariate results are reported. Bivariate 
analyses were conducted with three out of the four classes identified (Low-Blunt, Low-Bong, 
and Mod-Poly classes), while the High-Poly class could not be included in these bivariate 
analyses due to low frequencies. Comparisons between LCA classes were performed with the 
following variables: gender, race/ethnicity, school grades, past 30-day tobacco/nicotine use 
(collapsed across products), past 30-day use of individual tobacco/nicotine product types 
(cigarettes, traditional cigars, pipes, little cigars, electronic cigarettes, chew, dip/snuff, and 
hookah), lifetime alcohol use, BSSS score, cannabis dependence score, cannabis harm 
perceptions, and average cannabis occasions per month. Cases with “Other” as gender were 
excluded from Hypothesis 2 analyses, as well as cases with “Not sure” for school grades (n = 4), 
resulting in a sample size of 204 for Hypothesis 2. 
For Hypothesis 3, equivalence of groups randomized to each cannabis policy condition 
(three levels; legal-policy, medical-policy, illegal-policy) was assessed using bivariate tests 
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examining demographic items (gender, age, race/ethnicity), level of school attainment, year in 
college, school grades, current and previous state of residence, lifetime alcohol use, medicinal 
cannabis prescription, past-30 day tobacco use, lifetime cannabis use, past year cannabis use, 
past 30-day cannabis use, and baseline intentions to use cannabis. Items that differed 
significantly between cannabis policy conditions were included as covariates in the one-way 
ANCOVA models. Prior to conducting planned ANCOVAs, normality was assessed visually for 
each post-randomization outcome: cannabis attitudes, injunctive norms, perceived behavioral 
control, self-efficacy, and post-randomization intentions to use cannabis. Perceived behavioral 
control exhibited an extremely strong rightward skew (skewness = -1.87 and kurtotis value = 
4.45) due to a large proportion of responses at the highest value; this variable was transformed 
using the reflect and inverse formula (new variable = 1/(K – old variable) where K = largest 
possible value +1). Following any required transformations, between-subjects one-way 
ANCOVA were conducted for each post-randomization outcome. If the overall ANCOVA F-test 
was significant, post-hoc comparisons were completed using the Bonferroni correction to 
identify mean differences on dependent variables between each cannabis policy condition.  
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Results 
Total Sample Descriptives 
Table 5 displays demographics, cannabis use characteristics, and other substance use 
characteristics for the total sample (N = 457). Over two-thirds of the sample was female, and the 
average age of the sample was 20 years old. The sample was racially/ethnically diverse with 
42.5% identifying as “White or European-American,” 17.7% identifying as “Black, Afro-
Caribbean, or African American,” 14.4% identifying as “Asian-American,” 11.6% identifying as 
“Hispanic/Latino,” and 13.8% identifying as Multiracial or “Other.” Over two-thirds had used 
any tobacco product in the past month, and 91.7% of the sample had drank alcohol in their 
lifetime. Most of the sample had used cannabis in their lifetime (72.9%), 61.5% had used 
cannabis in the past year, and 45.5% had used cannabis in the past 30 days. Of past 30-day 
cannabis users, the most frequently used methods of cannabis administration were bong and 
blunt (over half of the sample) with bowl/pipe and joint used slightly less frequently (between 
40-50%; see Table 6). The least frequently used methods were edible and vaporizer/rig. Among 
past 30-day users, bong was used on the most occasions and days per month, followed by blunt 
and bowl/pipe. 
Descriptive analyses were conducted for the demographics of participants who were 
excluded from the analyses (n = 86), and bivariate analyses were conducted to compare 
demographics between included and excluded participants. A third of participants did not report 
age (31.4%); however, of those that did report age, the mean age was 20 years old. There was 
insufficient evidence to suggest there was a significant age difference between included and 
excluded participants. Similar patterns were reported for race/ethnicity; a third of participants did  
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Table 5. Total Sample Descriptives 
 Total N = 457 
Characteristic  n (%) or M (SD) 
Gender  
     Male 147 (32.2%) 
     Female 307 (67.2%) 
     Other 3 (0.7%) 
Age in years  20.04 (2.88) 
Race  
     White or European-American 194 (42.5%) 
     Black, Afro-Caribbean, or African American 81 (17.7%) 
     Asian-American 66 (14.4%) 
     Hispanic/Latino 53 (11.6%) 
     Multiracial/Other 63 (13.8%) 
Level of school attainment  
     High school or GED 210 (46.0%) 
     Some college/no degree 188 (41.1%) 
     Associate's or Bachelor's degree 57 (12.5%) 
     Missing 2 (0.4%) 
Year in college  
     1st 206 (45.1%) 
     2nd  95 (20.8%) 
     3rd 81 (17.7%) 
     4th 44 (9.6%) 
    5th or more 20 (4.4%) 
    Missing 11 (2.4%) 
School grades  
     Mostly A's 125 (27.4%) 
     Mostly B's  246 (53.8%) 
     Mostly C's, D's, or F's 77 (16.8%) 
     Not sure 6 (1.3%) 
     Missing 3 (0.7%) 
Current state of residence  
     Maryland 2 (0.4%) 
     New Jersey  1 (0.2%) 
     Virginia 454 (99.3%) 
Past state of residence  
     Virginia 405 (88.6%) 
     Other state 52 (11.4%) 
Lifetime alcohol use 419 (91.7%) 
Past 30-day tobacco use 306 (67.0%) 
Medicinal cannabis prescription 0 (0%) 
Lifetime cannabis use 333 (72.9%) 
Past year cannabis use 281 (61.5%) 
Past 30-day cannabis use 208 (45.5%) 
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Table 6. Characteristics of Past 30-day Users by Cannabis Administration Method 
 
 
Proportion of past 
30-day cannabis 
users* 
(%) 
Average cannabis 
use occasions in 
past 30   
M (SD) 
Average cannabis 
use days in past 30  
 
M (SD) 
Joint 40.0% 3.1 (8.7) 2.4 (5.8) 
Blunt 54.8% 4.4 (9.8) 3.9 (7.3) 
Bowl/pipe 50.0% 3.8 (8.6) 3.6 (7.1) 
Bong 54.8% 6.8 (15.0) 4.9 (8.8) 
Edible 27.4% 0.5 (1.3) 0.5 (1.2) 
Vaporizer/rig 19.2% 2.5 (11.9) 1.5 (5.4) 
Note: Asterisks (*) indicate these groups are non-exclusive. Mean (SD) occasions and 
days reported were specific to that method among past 30-day users.  
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Table 7. Latent Class Model Comparisons 
Number of classes AIC BIC Class.Err. L² Npar p 
1 2051.163 2084.538 0 421.6165 10 3.00E-18 
2 1915.844 1985.932 0.0212 264.2972 21 0.00017 
3 1894.96 2001.761 0.0179 221.4135 32 0.012 
4 1888.8 2032.314 0.1111 193.2536 43 0.065 
5 1887.246 2067.473 0.1533 169.6994 54 0.18 
6 1886.813 2103.753 0.0703 147.2663 65 0.39 
7 1889.126 2142.779 0.0811 127.5796 76 0.59 
8 1892.753 2183.119 0.0792 109.2069 87 0.77 
9 1896.935 2224.014 0.0602 91.3888 98 0.9 
10 1913.41 2277.201 0.0718 85.8632 109 0.82 
       
Bootstrapped 3 1894.96 2001.761 0.0179 221.4135 32 0.012 
Bootstrapped 4 1888.8 2032.314 0.1111 193.2536 43 0.065 
Note: Bolded text indicates final model selected. Class. Err. indicates classification 
error. Npar indicates number of parameters. 
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not report their race/ethnicity (33.7%). Of those that did report their race/ethnicity, 15.8% 
identified as “White or European-American,” 21.1% identified as “Black, Afro-Caribbean, or 
African American,” 21.1% identified as “Asian-American,” 19.3% identified as 
“Hispanic/Latino,” and 22.8% identified as Multiracial or “Other.” Chi-square analyses indicated 
there were significant differences of race/ethnicity between included and excluded participants (p 
< 0.005). Among participants who were excluded, 36% did not report their gender, and among 
those who did report gender, 47.3% identified as male and 52.7% identified as female. There was 
insufficient evidence to suggest there was a significant difference between the distribution of 
gender of included and excluded participants.  
Hypothesis 1 Results – LCA 
Based on the BIC, the fit of the model improved from a 1-class model (2084.54) to the 2-
class model (1985.93); however, the model fit weakened for the proceeding models (2001.76 – 
2277.20; See Table 7). Based on the AIC, the fit of the model improved from the 1-class model 
(2051.16) to the 6-class model (1886.81), but weakened following the 6-class model to the 10-
class model (1886.81 – 1913.41). Classification errors remained below 15% for all models. The 
1-class model had the highest L2 statistic (421.62) with gradually decreasing values with each 
subsequent model (264.30 – 85.86). The 1-class model had the lowest number of parameters 
(10), and the number of parameters increased with each subsequent model (21 – 109). Based on 
the AIC, BIC, classification error, L2 statistics, number of parameters, and the p-value, the 4-
model class was chosen as the best fit. The 4-class model with and without bootstrapping had an 
AIC of 1888.8, a BIC of 2032.3, a classification error of 11.1%, an L2 statistic of 193.3, 43 
parameters, and p = 0.065. 
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Table 8 displays the conditional probabilities and the assigned labels of the selected 4-
class model. Conditional probabilities ranging from 0-0.30 are considered low, 0.31-0.60 are 
considered moderate, and 0.61-0.99 are considered high (personal communication with A. 
Nasim; Nasim et al., 2012; Nasim et al., 2016). The Low-Blunt class was the largest class, 
representing 60.1% of past 30-day cannabis users (n = 125). The Low-Blunt class was 
characterized by a high probability of using blunts 1-10 times per month and high probabilities 
of using joints, bowls/pipes, bongs, edibles, and vaporizers/rigs 0 times per month. The Low-
Bong class contained 23.6% of past 30-day cannabis users (n = 49). The Low-Bong class had a 
high probability of using bongs 1-10 times per month. The Low-Bong class had high 
probabilities of using joints, blunts, edibles, and vaporizers/rigs 0 times per month and had a 
moderate probability of using bowls/pipes 0 times per month and 1-10 times per month. The 
Mod-Poly class consisted of 12.5% of past 30-day cannabis users (n = 26). The Mod-Poly class 
had high probabilities of using joints, blunts, and bowls/pipes 1-10 times per month and of using 
bongs 10 or more times per month. The Mod-Poly class also had high probabilities of using 
edibles and vaporizers/rigs in the past month. The High-Poly class was the smallest class, which 
accounted for 3.8% of the sample (n = 8). The High-Poly class was characterized by high 
probabilities of using joints, blunts, bowls/pipes, and bongs 10 or more times per month and of 
using edibles and vaporizers in the past month. 
Hypothesis 2 Results – Descriptives 
There were significant differences between the three largest LCA classes (i.e., Low-
Blunt, Low-Bong, and Mod-Poly; n = 196) and the distribution of gender (p = 0.05; See Table 
9). The Low-Blunt class consisted of 73.8% females, while the Low-Bong and Mod-Poly classes   
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Table 8. Latent Class Analysis Probabilities 
 
Low-
Blunt 
Low-
Bong 
Mod-
Poly 
High-
Poly 
Reported cluster size from Latent Gold  59.6% 23.3% 13.1% 4.0% 
Actual calculated cluster size 60.1% 23.6% 12.5% 3.8% 
n = 208 n = 125 n = 49 n = 26 n = 8 
Past 30-day occasions of joint use     
0 times 0.64 0.89 0.07 0.02 
1-10 times 0.31 0.02 0.93 0.01 
10+ times 0.04 0.09 0.00 0.97 
Past 30-day occasions of blunt use     
0 times 0.46 0.76 0.00 0.01 
1-10 times 0.54 0.06 0.81 0.01 
10+ times 0.00 0.18 0.19 0.97 
Past 30-day occasions of bowl/pipe use     
0 times 0.63 0.40 0.20 0.14 
1-10 times 0.33 0.46 0.69 0.14 
10+ times 0.04 0.14 0.11 0.73 
Past 30-day occasions of bong use     
0 times 0.68 0.19 0.00 0.02 
1-10 times 0.32 0.63 0.37 0.01 
10+ times 0.00 0.18 0.62 0.97 
Past 30-day use of edibles     
No 0.78 0.93 0.31 0.14 
Yes 0.22 0.07 0.69 0.86 
Past 30-day vaporizer/rig use     
No 0.91 0.94 0.18 0.63 
Yes 0.09 0.06 0.82 0.37 
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Table 9. Hypothesis 2 Descriptives and Bivariate Associations with Latent Class Analysis Class 
Status 
 Low-Blunt Low-Bong Mod-Poly  High-Poly 
 n = 122 n = 48 n = 26  n = 8 
Characteristics 
n (%) or  
M (SD) 
n (%) or  
M (SD) 
n (%) or  
M (SD) p 
n (%) or  
M (SD) 
Gender    0.045  
     Male 32 (26.2%) 20 (41.7%) 12 (46.2%)  3 (37.5%) 
     Female 90 (73.8%) 28 (58.3%) 14 (53.8%)  5 (62.5%) 
Race/Ethnicity    0.021  
     White 45 (36.9%) 27 (56.3%) 16 (61.5%)  4 (50.0%) 
     Black 31 (25.4%) 7 (14.6%) 2 (7.7%)  1 (12.5%) 
     Asian 8 (6.6%) 5 (10.4%) 3 (11.5%)  -- 
     Hispanic/Latino 20 (16.4%) 1 (2.1%) 4 (15.4%)  1 (12.5%) 
     Multiracial/Other 18 (14.8%) 8 (16.7%) 1 (3.8%)  2 (25.0%) 
School Grades    0.218  
     Mostly A's 21 (17.2%) 14 (29.2%) 6 (23.1%)  -- 
     Mostly B's 80 (65.6%) 24 (50.0%) 18 (69.2%)  3 (37.5%) 
     Mostly C's, D's, or F's 21 (17.2%) 10 (20.8%) 2 (7.7%)  5 (62.5%) 
Past 30-day tobacco use 56 (45.9%)~ 26 (54.2%) 19 (73.1%)~ 0.039 6 (75.0%) 
Past 30-day cigarettes 30 (24.6%) 18 (37.5%) 11 (42.3%) 0.088 4 (50.0%) 
Past 30-day traditional cigars 5 (4.1%) 1 (2.1%) 2 (7.7%) N/A -- 
Past 30-day pipe 2 (1.6%) -- -- N/A -- 
Past 30-day little cigars 20 (16.4%) 8 (16.7%) 9 (34.6%) 0.088 5 (62.5%) 
Past 30-day electronic 
cigarettes 6 (4.9%)*^ 8 (16.7%)^ 7 (26.9%)* 0.001 2 (25.0%) 
Past 30-day chew 1 (0.8%) 1 (2.1%) -- N/A -- 
Past 30-day dip/snuff 1 (0.8%) 2 (4.2%) 3 (11.5%) N/A -- 
Past 30-day hookah 13 (10.7%) 5 (10.4%) 6 (23.1%) 0.194 -- 
Lifetime alcohol use 122 (100.0%) 47 (97.9%) 26 (100.0%) N/A 8 (100.0%) 
Sensation seeking (BSSS) 25.8 (5.5) 25.9 (5.2) 28.4 (4.9) 0.072 26.8 (6.2) 
Cannabis dependence score 5.8 (1.7)* 6.5 (2.1) 7.4 (2.7)* 0.008 7.1 (2.6) 
Cannabis harm perceptions 2.7 (1.4) 2.6 (1.2) 2.7 (1.2) 0.937 1.9 (0.7) 
Average days of cannabis use per 
month 6.4 (7.7)*^ 12.2 (11.3)^~ 25.2 (7.7)*~ <0.001 28.4 (3.5) 
Note: Bivariate tests (chi-square, ANOVA) and associated p-values compared data among the Low-Blunt, Low-Bong, 
and Mod-Poly classes; High-Poly was excluded due to low frequencies. Welch test was used due to violation of 
homogeneity of variance for cannabis dependence and average days of cannabis use per month. N/A indicates that at 
least 30% of expected cell counts were less than 5; therefore, bivariate statistical results were unreliable. Asterisks (*) 
indicate a significant difference at the 0.05 level between Low-Blunt and Mod-Poly. Carets (^) indicate a significant 
difference at the 0.05 level between Low-Blunt and Low-Bong. Tildes (~) indicate a significant difference at the 0.05 
level between Low-Bong and Mod-Poly. For past 30-day tobacco use, no participants reported dissolvable tobacco, 
snus, or nicotine replacement therapy use.
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consisted 58.3% and 53.8% females, respectively. There were significant differences between 
LCA class and the distribution of race/ethnicity (p = 0.02). The Low-Blunt class had a higher 
proportion of individuals of Hispanic/Latino and Black race/ethnicity than the Low-Bong and 
Mod-Poly classes. The Low-Bong class and Mod-Poly class primarily consisted of individuals of 
White race/ethnicity (56.3% and 61.5%, respectively). There were also significant differences 
between the three LCA classes and the distribution of past 30-day tobacco use (p = 0.04). 
Approximately 73% of the Mod-Poly class were past 30-day tobacco users compared to 46% of 
the Low-Blunt class and 54% of the Low-Bong class. There were significant differences between 
the LCA classes and endorsement of past 30-day use of electronic cigarettes (p = 0.001). In the 
Mod-Poly class, 26.9% had used an electronic cigarette in the past 30 days compared to only 
16.7% in the Low-Bong class and 4.9% in the Low-Blunt class. Due to violations in 
homogeneity of variance, the adjusted F test (i.e., Welch statistic) indicated that there was a 
significant difference between the three LCA classes and cannabis dependence, F(2, 54) = 5.327, 
p = 0.01. There were statistically significant differences between average cannabis dependence 
scores for the Mod-Poly class and the Low-Blunt class, such that that Mod-Poly class had a 
higher cannabis dependence score. There were significant differences between the three LCA 
classes and average monthly cannabis use in days, F(2, 59) = 63.747, p < 0.001. There were 
statistically significant differences between the Low-Blunt and Low-Bong classes, the Low-
Bong class and the Mod-Poly class, as well as, the Low-Blunt and Mod-Poly classes.  
Hypothesis 3 Results – Cannabis Policy Conditions 
 Results for bivariate and ANCOVA analyses are presented in Tables 10 and 11. For 
bivariate associations between the cannabis policy conditions and the potential covariates, results   
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Table 10. Hypothesis 3 Descriptives and Bivariate Associations by Cannabis Policy Condition 
 Legal-policy Medical-policy Illegal-policy 
 
 n = 149 n = 150 n = 147 
 
Characteristic n (%) or M (SD) n (%) or M (SD) n (%) or M (SD) p 
Gender    0.872 
     Male 46 (30.9%) 50 (33.3%) 49 (33.3%)  
     Female 103 (69.1%) 100 (66.7%) 98 (66.7%)  
Age in years 20.2 (3.1) 20.0 (2.5) 19.9 (3.1) 0.578 
Race    0.187 
     White 68 (45.6%) 71 (47.3%) 50 (34.0%)  
     Black 31 (20.8%) 22 (14.7%) 25 (17.0%)  
     Asian 19 (12.8%) 22 (14.7%) 23 (15.6%)  
     Hispanic/Latino 16 (10.7%) 15 (10.0%) 22 (15.0%)  
     Multiracial/Other 15 (10.1%) 20 (13.3%) 27 (18.4%)  
Level of school attainment    0.171 
     High school or GED 60 (40.5%) 72 (48.3%) 73 (49.7%)  
     Some college/no degree 62 (41.9%) 62 (41.6%) 60 (40.8%)  
     Associate's or Bachelor's 
degree 
26 (17.6%) 15 (10.1%) 14 (9.5%)  
Year in college    0.002 
     1st 54 (36.7%) 66 (45.2%) 82 (56.9%)  
     2nd  35 (23.8%) 36 (24.7%) 23 (16.0%)  
     3rd 40 (27.2%) 20 (13.7%) 19 (13.2%)  
     4th 14 (9.5%) 14 (9.6%) 16 (11.1%)  
    5th or more 4 (2.7%) 10 (6.8%) 4 (2.8%)  
School grades    0.024 
     Mostly A's 34 (22.8%) 48 (32.0%) 42 (28.6%)  
     Mostly B's  95 (63.8%) 68 (45.3%) 83 (56.5%)  
     Mostly C's, D's, or F's 20 (13.4%) 34 (22.7%) 22 (15.0%)  
Current state of residence    N/A 
     Maryland 2 (1.3%) -- --  
     New Jersey  -- -- 1 (0.7%)  
     Virginia 147 (98.7%) 150 (100.0%) 146 (99.3%)  
Past state of residence    0.313 
     Virginia 129 (86.6%) 138 (92.0%) 130 (88.4%)  
     Other state 20 (13.4%) 12 (8.0%) 17 (11.6%)  
Lifetime alcohol use 137 (91.9%) 136 (90.7%) 135 (91.8%) 0.908 
Medicinal cannabis prescription 0 (0%) 0 (0%) 0 (0%) -- 
Past 30-day tobacco use 44 (29.5%) 54 (36.0%) 51 (34.7%) 0.456 
Lifetime cannabis use 102 (68.5%) 117 (78.0%) 107 (72.8%) 0.176 
Past year cannabis use 84 (56.4%) 97 (64.7%) 94 (63.9%) 0.476 
Past 30-day cannabis use 67 (45.0%) 66 (44.0%) 71 (48.3%) 0.186 
Baseline intentions to use 
cannabis 
8.5 (6.6) 9.8 (6.7) 10.5 (7.3) 0.030 
Note: Welch test was used due to violation of homogeneity of variance for baseline intentions to use 
cannabis; N/A indicates that at least 30% of expected cell counts were less than 5; therefore, bivariate 
statistical results were unreliable.
  
60 
 
 
Table 11. Analysis of Covariance Results for Experimental Outcomes 
 
Overall 
Sample 
 Legal-policy Medical-policy Illegal-policy  
Outcome measure M (SE)  M (SE) M (SE) M (SE) p 
Attitudes about cannabis 15.1 (0.4)  16.2 (0.6)* 16.4 (0.5)^ 12.6 (0.6)*^ <0.001 
Injunctive norms 7.9 (0.2)  8.2 (0.3) 8.2 (0.3) 7.4 (0.3) 0.045 
Perceived behavioral control (PBC) 18.5 (0.2)  18.8 (0.3) 18.6 (0.3) 18.0 (0.3) 0.170 
     Log-transformed PBC 0.6 (0.2)  0.7 (0.04) 0.6 (0.03) 0.6 (0.04) 0.443 
Self-efficacy to use cannabis 19.8 (0.3)  20.6 (0.6)* 20.4 (0.5)^ 18.3 (0.6)*^ 0.005 
Post-randomization intentions to use 
cannabis 
10.2 (0.2)  11.0 (0.3)* 10.4 (0.3)^ 9.3 (0.3)*^ <0.001 
Note: M (SE) reported above include covariates appearing in the model evaluated at the following values: school year = 2.04, past 30-
day cannabis use = 0.4577, and baseline intentions to use cannabis = 9.59. Attitude scores ranged from 7 to 28. Higher mean attitude 
scores indicated more favorable attitudes about cannabis. Injunctive norm scores ranged from 7 to 21. Higher mean injunctive norms 
scores indicated a higher agreement that social supporters think they should use cannabis. PBC scores ranged from 7 to 21. Higher 
mean scores for PBC indicated stronger beliefs that a person is able to use cannabis. Self-efficacy scores ranged from 7 to 28. Higher 
mean self-efficacy scores indicated a higher self-confidence in the ability to use cannabis. Post-randomization intentions scores ranged 
from 7 to 21. Higher mean post-randomization intentions scores indicated higher intentions to use cannabis. Asterisks (*) indicate a 
significant difference at the 0.05 level between illegal condition and legal condition. Carets (^) indicate a significant different at the 
0.05 level between medical condition and illegal condition.  
  
61 
 
indicated that there were significant differences between the cannabis policy conditions and year 
in college (p = 0.002) and school grades (p = 0.024) as well as baseline intentions to use 
cannabis (p = 0.030; See Table 10). These three variables were included as covariates in the 
subsequent ANCOVAs, as well as past 30-day cannabis use due to this behavior’s salience in the 
analysis outcomes.  
Among the planned five ANCOVAs conducted controlling for year in school, school 
grades, past 30-day cannabis use, and baseline intentions to use cannabis, four outcomes had a 
significant effect of cannabis policy condition (see Table 11). There was a significant effect of 
cannabis policy condition on attitudes about cannabis, F(2, 429) = 15.590, p < 0.001. Post-hoc 
comparisons using the Bonferroni correction revealed the legal-policy and medical-policy 
conditions resulted in significantly more positive attitudes about cannabis relative to the illegal-
policy condition (ps < 0.05). However, the cannabis attitudes in the legal-policy condition did 
not significantly differ from the medical-policy condition. 
There was a significant effect of cannabis policy condition on injunctive norms for 
cannabis use, F(2, 429) = 3.115, p = 0.045. Post-hoc comparisons revealed there were no 
differences between cannabis policy conditions although descriptively the illegal-policy 
condition had the lowest injunctive norms relative to the medical-policy condition and the legal-
policy condition. 
There was insufficient evidence to suggest there was a significant effect of cannabis 
policy condition on perceived behavioral control, F(2, 429) = 1.777, p = 0.170.  
There was a significant effect of cannabis policy condition on self-efficacy, F(2, 429) = 
5.409, p = 0.005. Post-hoc comparisons using the Bonferroni correction revealed the legal-policy 
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and the medical-policy conditions resulted in significantly higher self-efficacy scores compared 
to the illegal-policy condition (ps < 0.05). However, the mean self-efficacy scores in the legal-
policy condition did not significantly differ from the medical-policy condition. 
There was a significant effect of cannabis policy condition on post-randomization 
intentions to use cannabis, F(2, 429) = 10.802, p < 0.001. Post-hoc comparisons using the 
Bonferroni correction revealed the legal-policy and medical-policy conditions resulted in 
significantly higher post-randomization intentions to use cannabis score relative to the illegal-
policy condition (ps < 0.05). However, the post-randomization intentions to use cannabis score in 
the legal-policy condition did not significantly differ from the mean score in the medical-policy 
condition. 
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Discussion 
The purpose of the current study was 1) to assess patterns of cannabis consumption 
among young adults using LCA, 2) to determine if these patterns were associated with 
differential demographics and other factors, as well as 3) to test if hypothetical cannabis policy 
environments influenced attitudes about cannabis, injunctive norms, perceived behavioral 
control, self-efficacy, and intentions to use cannabis among young adults. Approximately 450 
students completed the study and 45% were current (past 30-day) cannabis users. Four latent 
classes of cannabis users based on frequency of past 30-day administration methods of cannabis 
use were identified. Three of the largest classes differed by gender, race/ethnicity, past 30-day 
tobacco use, past 30-day electronic cigarette use, cannabis dependence, and average days of 
cannabis use per month. These data reveal unique groups of cannabis users that can be targeted 
more effectively for prevention and intervention efforts. As this study was conducted in an 
illegal cannabis policy environment, it would be valuable to identify if these same sub-groups of 
cannabis users exist in a legal cannabis policy environment and/or medicinal cannabis policy 
environment. In Hypothesis 3, results indicated that legal and medicinal cannabis policy 
conditions increased attitudes about cannabis, injunctive norms, self-efficacy, and intentions to 
use cannabis relative to the illegal cannabis policy condition. These data reveal that a simple 
hypothetical policy manipulation can change intentions to use cannabis. Based on the TPB, these 
behavioral intentions may lead to changes in behaviors. It is plausible that real changes in 
cannabis policies can alter cannabis use; however, more research is needed in real-life situations 
in order to explore this association.  
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Hypothesis 1  
For Hypothesis 1, we expected to find a large class of young adults who used 
combustion-based methods of cannabis (e.g., joints, blunts, bongs). However, in the current 
study, four latent classes were identified (Low-Blunt, Low-Bong, Mod-Poly, High-Poly), where 
several specific methods of administration were highlighted, as well as varying frequencies of 
use. Previous literature has often compared cannabis users to non-users, implying that cannabis 
users are a homogenous group (Lipperman-Kreda, Paschall, Robert, & Morrison, 2017; 
Pedersen, Hummer, Rinker, Traylor, & Neighbors, 2016); however, data from the current study 
revealed that there are unique sub-groups among cannabis users. The Low-Blunt and the Low-
Bong classes comprised over three-quarters of the sample (84%), and both were characterized by 
high probabilities of using either blunts or bongs between 1-10 times per month. On the other 
hand, the Mod-Poly and High-Poly classes were smaller in size (4-13%) and were characterized 
by high probabilities of using all methods of cannabis administration and for some, at higher 
frequencies (10+ times per month). The Mod-Poly class was characterized by high probabilities 
of using edibles and rigs/vaporizers, while the High-Poly class was characterized by a high 
probability of using edibles but a low probability of using rigs/vaporizers. 
Although several studies have conducted LCAs on cannabis users (Baggio et al., 2014; 
Krauss, Rajbhandari, Sowles, Spitznagel, & Cavazos-Rehg, 2017; Pearson et al., 2017), none 
have used this type of analysis with the inclusion of a range of cannabis methods of 
administration as well as use frequencies of these methods. One longitudinal Swiss study 
conducted between 2010 and 2011 identified sub-groups of male adult cannabis users based on 
methods of administration; however, the study only included frequencies of joints, cannabis 
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“mixed with food,” and water pipes in their LCA (Baggio et al., 2014). Results indicated that 
joint users comprised the largest latent class, followed by users who reported low frequencies of 
joints, water pipes, and cannabis “mixed with food” and users who reported high frequencies of 
joints, water pipes, and cannabis “mixed with food” (Baggio et al., 2014). Contrasting from the 
Baggio et al. (2014) article, the inclusion of more methods of cannabis administration revealed a 
Low-Blunt class and a Low-Bong class, but similarly to the Baggio et al. (2014) study, the 
smallest class in both studies was the high frequency use of multiple methods of cannabis 
administration (i.e., High-Poly class).  
Compared to studies that measured the use of different cannabis methods of 
administration, several similarities were apparent. The use of blunts and bongs were most 
frequently reported among past 30-day cannabis users in the present sample (54.8% and 54.8%, 
respectively), which corroborates findings from past literature among an adult population 
recruited online between 2010-2012 (Hughes et al., 2014). However, our results differed from a 
study conducted in 2014 among a representative nationwide sample of adults which reported 
bowl/pipe use as the most frequently endorsed method of administration (50%), followed by 
joints (49%), bongs (22%), and vaporizers (8%; Schauer et al., 2016). These discrepancies 
between studies could exist due to the changes in cannabis policies since 2010, which could have 
affected nationwide patterns of use and/or due to the changes in cannabis policies by state. The 
current study was conducted in a Mid-Atlantic state, whereas the aforementioned studies were 
conducted with nationwide samples (Hughes et al., 2014; Schauer et al., 2016). Also consistent 
with past literature, use of multiple methods was common in two latent classes (i.e., Mod-Poly 
and High-Poly; Hughes et al, 2014; Schauer et al., 2016).  
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Hypothesis 2 
For Hypothesis 2, we expected to identify differences between latent classes on 
demographics, harm perceptions, and risk-taking behaviors. However, the LCA revealed four 
latent classes which limited our analyses to simpler techniques than were proposed. Therefore, 
bivariate statistics were conducted to describe the data. We found significant differences between 
three latent classes (i.e., Low-Blunt, Low-Bong, Mod-Poly) by gender, race/ethnicity, past 30-
day tobacco use, past 30-day electronic cigarette use, cannabis dependence, and average days of 
cannabis use per month. 
Low-Blunt users were primarily female (73.8%) and were more racial/ethnical diverse 
with a high proportion of people who identified as Black (25.4%) compared to the other classes 
(Low-Bong 14.6%; Mod-Poly 7.1%). Almost half of Low-Blunt users reported past 30-day 
tobacco use, and Low-Blunt users reported a significantly lower amount of past 30-day 
electronic cigarette use compared to the Low-Bong and Mod-Poly classes. Cannabis dependence 
was significantly lower in the Low-Blunt class compared to the Mod-Poly class, and on average, 
the Low-Blunt class reported the lowest number of days of past month cannabis use.  
The Low-Bong class consisted of a higher proportion of females than males (58.3% vs. 
41.7%), and these individuals primarily identified as White (56.3%). Over half of the Low-Bong 
users reported past 30-day tobacco use and significantly more Low-Bong users reported 
electronic cigarette use compared to the Low-Blunt class. The Low-Bong class reported a 
significantly higher average number of days of cannabis use per month compared to the Low-
Blunt class; however, the Low-Bong class reported a significantly lower average number of days 
of cannabis use per month compared to the Mod-Poly class.  
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The Mod-Poly class also consisted of more females than males (53.8% vs. 46.2%), and 
they primarily identified as White (61.5%). The Mod-Poly class had the highest proportion of 
past 30-day tobacco users compared to the Low-Blunt and Low-Bong classes with a significant 
difference between the Low-Blunt and Mod-Poly classes. The Mod-Poly class also reported the 
highest proportion of past 30-day electronic cigarette use which was significantly higher than the 
Low-Blunt class and the Mod-Poly class. Cannabis dependence was highest in the Mod-Poly 
class, which was significantly higher than the Low-Blunt class. Finally, the average days of 
cannabis use per month was significantly higher in the Mod-Poly class compared to both Low-
Blunt and Low-Bong classes.  
The High-Poly class consisted of more females than males (62.5% vs. 37.5%) and was 
ethnically/racially diverse with half of the sample identifying as White and a quarter of the 
sample identifying as Multiracial/Other. The High-Poly class earned mostly C, D, or F grades in 
school. The High-Poly class endorsed the highest proportion of past 30-day tobacco use 
compared to the other three classes, as well as the highest proportion of past 30-day cigarette use 
and little cigar use. Cannabis dependence in the High-Poly class was similar to cannabis 
dependence scores in the Mod-Poly class. Interestingly, the High-Poly class reported the lowest 
cannabis harm perceptions compared to the other three classes. Finally, the High-Poly class, on 
average, used cannabis almost every day in the past 30 days.  
There were no significant differences between the Low-Blunt, Low-Bong, and Mod-Poly 
classes on school grades, past 30-day cigarette, traditional cigars, tobacco pipes, little cigars, 
chew, dip/snuff, or hookah, lifetime alcohol use, sensation seeking, or cannabis harm 
perceptions.  
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Due to the limited literature on cannabis methods of administration, many of the current 
findings are unique to the current study. However, past literature has explored some correlates of 
specific methods of cannabis administration which can allow for some comparisons to current 
study result. Past literature has indicated that blunt users are more likely to identify as female and 
Black, non-Hispanics, which is consistent with the Low-Blunt class (A. Cohn et al., 2016; J. R. 
Hughes et al., 2014; Timberlake, 2009). More frequent cannabis use has been correlated with 
vaporizer use, which is consistent with the Mod-Poly class (D. C. Lee et al., 2016). Importantly, 
previous literature on correlates of cannabis administration methods has not included frequencies 
of administration method use. Further research is needed to replicate the findings in the current 
study in order to inform intervention efforts for these sub-groups of cannabis users.   
The results indicate that there are unique groups of cannabis users which can be targeted 
for specific intervention. Evidence-based cannabis interventions most often consist of cognitive 
behavioral therapy, contingency management, motivational enhancement therapy, or a 
combination of these interventions (NIDA, 2012). Cognitive behavioral therapy involves the 
development of coping skills in order to manage and/or abstain from substance use (NIDA, 
2012). Contingency management interventions consist of providing a monetary or voucher 
incentive (which acts as a positive reinforcement) to refrain from substance use (NIDA, 2012). 
Finally, motivational enhancement therapy is a form of counseling in which internal motivation 
is fostered in the client in order to promote abstinence (NIDA, 2012). Although these cannabis 
interventions are widely used and often result in abstinence, previous research on cannabis 
interventions generalize cannabis users as a homogenous group (ignoring the various methods of 
cannabis administration; e.g., Budney, Moore, Rocha, & Higgins, 2006; Carroll et al., 2006; 
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Marijuana Treatment Project Research, 2004; Schuster et al., 2016). Based on the findings from 
the current study, it may be useful to apply these interventions to specific groups of cannabis 
users. Regarding the current study, the largest latent class, the Low-Blunt class, could benefit 
from cognitive behavioral therapy that specifically targets blunt use and highlights its risks 
including the harms of acute exposure to tobacco products (i.e., in the blunt wrap).  
Although cannabis interventions often target cannabis users without the consideration of 
the various methods of cannabis administration, cannabis interventions also focus on and are 
sought by dependent cannabis users. The Mod-Poly and High-Poly classes had the highest levels 
of cannabis dependence and frequency of use, suggesting potentially more severe substance use 
disorder symptomology and that more intensive treatment strategies, such as a combination of 
cognitive behavioral therapy and contingency management, would benefit these individuals. 
Contingency management interventions have often been used with adolescent cannabis users; 
however, contingency management interventions may be also useful for young adult cannabis 
users who may not have a desire to abstain from cannabis use. Previous literature conducted in 
2009 on young adults’ interest in receiving cannabis treatment indicated that less frequent 
cannabis use was associated with a decreased interest to participate in cannabis treatment 
(Buckner, Ecker, & Cohen, 2010). Due to the low frequency of cannabis use in the Low-Blunt 
and Low-Bong classes in the current study, these users may benefit from motivational 
enhancement therapy, in order to increase the desire to participate in cannabis treatment and 
abstain from cannabis use. Importantly, all classes were likely to report concurrent tobacco use 
(46-75%) consistent with other literature regarding the co-occurrence of substance use behavior 
(Agrawal & Lynskey, 2009; Schauer, Berg, Kegler, Donovan, & Windle, 2015, 2016). Effective 
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interventions may be best served to incorporate features of tobacco and cannabis use cessation; it 
may be most advantageous to target both substances at the same time (Becker, Haug, Kraemer, 
& Schaub, 2015; Becker, Haug, Sullivan, & Schaub, 2014; Becker et al., 2013). These results 
also indicate a need for clinical practitioners and researchers to avoid treating past month 
cannabis users as one homogenous group during assessment. Asking about the individual’s 
unique patterns of cannabis use (i.e., their methods of cannabis administration) lends a better 
understanding to the individual’s specific harm potential.   
The latent classes identified in the current study were characterized by unique 
combinations of cannabis methods of use which may be related to harmfulness. Available 
research has indicated that there may be differential health effects associated with the various 
methods of cannabis administration. For example, combustion-based methods of cannabis 
administration (e.g., blunts and joints) are associated with increased coughing, exposure to 
carbon monoxide, and the development of lung disease and cancer (Martinasek et al., 2016; 
Yayan & Rasche, 2016). In the current study, the two largest classes, Low-Blunt and Low-Bong, 
were characterized by methods of cannabis administration that rely on combustion. These two 
classes may experience similar combustion-related negative health effects. The Mod-Poly and 
High-Poly classes were characterized by use of all methods of administration including 
combusted and non-combusted. These classes may be exposed to combustion-based negative 
health effects, as well as negative health effects from using other methods of administration. For 
example, both the Mod-Poly and High-Poly classes resulted in high probabilities of using 
edibles, and the use of edibles is associated with mouth irritation (Cho et al., 2005). It is 
unknown whether the use of multiple methods of cannabis administration is associated with a 
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greater number of negative health effects. More research is needed to explore the potential 
additive negative health effects of multiple methods of cannabis administration.  
Hypothesis 3 
The purpose of Hypothesis 3 was to test if hypothetical cannabis policy environments 
influenced attitudes about cannabis, injunctive norms, perceived behavioral control, self-
efficacy, and intentions to use cannabis among young adults. We expected the legal-policy 
condition would elicit the highest intentions to use cannabis, followed by the medical-policy 
condition and the illegal-policy condition. We expected self-reported attitudes, injunctive norms, 
perceived behavioral control, and self-efficacy to be highest in the legal-policy condition and 
lowest in the illegal-policy condition.  
Consistent with our hypotheses, attitudes about cannabis were significantly different 
across cannabis policy environments when controlling for year in school, school grades, past 30-
day cannabis use, and baseline intentions to use cannabis. The illegal drug condition was 
associated with significantly less favorable attitudes about cannabis compared to the legal-policy 
condition and the medical-policy condition. The medical-policy condition was associated with 
the most favorable attitudes about cannabis, but the medical-policy condition did not 
significantly differ from the legal-policy condition. There were significant differences between 
cannabis policy environments and injunctive norms. The legal- and medical-policy conditions 
were associated with higher injunctive norms compared to the illegal-policy condition. More 
simply stated, those in the legal- and medical-policy conditions more often agreed that their 
social supporters (i.e., family members and important others) think they should use cannabis. 
Inconsistent with our hypotheses, perceived behavioral control did not differ across cannabis 
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policy environments. Self-efficacy to use cannabis differed significantly across cannabis policy 
environments. The legal-policy and the medical-policy conditions were associated with 
significantly higher self-efficacy to use cannabis scores compared to the illegal-policy condition. 
The illegal-policy condition was associated with significantly less self-efficacy to use cannabis 
compared to the medical-policy condition and the legal-policy condition. The legal-policy 
condition had the highest self-efficacy to use cannabis scores, but the legal-policy condition did 
not significantly differ from the medical-policy condition. Finally, the post-randomization 
intentions to use cannabis differed across cannabis policy conditions. Similar to previous results, 
the legal-policy and medical-policy conditions were associated with significantly higher 
intentions to use cannabis compared to the illegal-policy condition, with the legal-policy 
condition resulting in the highest intentions to use cannabis.  
These results indicate that using an experimental design with a behavior change theory 
rationale results in differences in intentions to use cannabis across hypothetical cannabis policy 
conditions. Intentions to use is the most closely-related antecedent to actual behavior in the TPB. 
Therefore, these data could point to potential changes in cannabis use patterns due to cannabis 
policy changes, such that more relaxed cannabis policies elicit higher intentions to use cannabis 
among young adults. Although these results were found in the current study, longitudinal data 
collected in California from 1995 to 1999 (prior to and following the legalization of cannabis for 
medicinal purposes) indicated that actual cannabis use behaviors did not increase among all age 
groups as a function of legalizing medicinal cannabis in 1996 (Khatapoush & Hallfors, 2004). 
More recent research using combined longitudinal data from MTF (from 1991-2014), the 
National Longitudinal Surveys of Youth (from 1997-2005), the YRBS (from 1991-2011) and the 
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NSDUH (from 2002-2013) indicated that adolescents’ use of cannabis did not significantly 
increase after medical cannabis laws were enacted; however, in the same study, according to the 
NSDUH (from 2004-2013) and the National Institute on Alcohol Abuse and Alcoholism surveys 
(from 1991-2012), cannabis use increased among adults after legalization of cannabis for 
medicinal use (Carliner, Brown, Sarvet, & Hasin, 2017). This discrepancy provides motivation 
for more longitudinal research across many states to determine the real-life, long-term effects of 
cannabis policy changes across different ages. 
Results from Hypothesis 3 also indicated that attitudes about cannabis were significantly 
most favorable in the medical-policy and legal-policy conditions compared to the illegal-policy 
condition. This finding is unsurprising, given that favorable cannabis attitudes tend to coincide 
with the legalization of cannabis for recreational and medicinal purposes. This finding is 
consistent with a study that used data from the NSDUH (from 2003-2011) on the differences 
between adults’ cannabis attitudes in Colorado (during which the state allowed the use of 
cannabis only for medicinal purposes) compared to 34 states that had illegal cannabis policies at 
the time (Schuermeyer et al., 2014). Results indicated that adults in Colorado had significantly 
higher approval rates for cannabis use compared to adults in states with illegal cannabis laws 
(Schuermeyer et al., 2014). Importantly, among Colorado and states with illegal cannabis laws, 
approval rates for cannabis increased from 2003 to 2011 (Schuermeyer et al., 2014). Taken 
together, evidence suggests that less restrictive cannabis policy is associated with more favorable 
attitudes toward cannabis. Further research should continue to monitor cannabis attitudes in 
states with legalized cannabis for recreational and/or medicinal purposes, as well as, monitor 
nationwide trends on cannabis attitudes. 
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Limitations 
There were several limitations to the current study. One common to surveys among 
specific college-based samples relates to generalizability. It is possible that results found here 
may be specific to the geographic region and time due to differences in environmental influences 
as well as relevant policies. Social desirability bias also may have influenced self-reports of 
marijuana use (Welte & Russell, 1993); although the data collection techniques (data were never 
linked to participant names) may have reduced this effect. Previous studies have also relied on 
self-report for other substance behaviors that are restricted (i.e., alcohol) and shown them to be 
valid and reliable (Del Boca & Darkes, 2003). However, recall errors may have also occurred in 
the current study. Future research should utilize multiple methods of self-report (e.g., timeline 
follow back) in order to increase reliability (Hjorthoj, Hjorthoj, & Nordentoft, 2012). Another 
limitation to the current study is the use of a hypothetical policy environment to invoke changes 
in behavioral intentions. Although the results of the study showed a successful policy 
manipulation, conducting this study across US states with varying policy environments would 
have been stronger in order to better generalize to other populations. Regarding methods, the 
survey did not ask about health status of the participant themselves or of their family members. 
Differences in these variables could have affected the injunctive norms which asked about the 
perception of family members’ opinions about cannabis use. For example, if a family member is 
sick and uses cannabis medicinally, injunctive norms of the participant could be elevated 
compared to participants without this influence. Although unknown prior to the study, a larger 
sample size would have allowed for sufficient power to conduct regression analyses for 
Hypothesis 2.  
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Conclusions and Future Directions 
The current study identified four unique sub-groups of cannabis users and differential 
demographics, tobacco, and cannabis use behaviors between these groups. Using the results from 
this study, these sub-groups of cannabis users can be more effectively targeted for intervention 
efforts. These results also provide support for the notion that cannabis users have heterogeneous 
use patterns which may be associated with differential harms. Results from the current study also 
indicated that a recreationally and medicinally legalized cannabis policy environment increased 
attitudes, injunctive norms, self-efficacy, and intentions to use cannabis. Using the TPB as 
context for these findings, cannabis use behaviors could increase due to the legalization of 
cannabis for recreational or medicinal purposes. Therefore, studying attitudes about cannabis, 
self-efficacy to use cannabis, and intention to use cannabis in real-life situations in a variety of 
states, pre- and post-policy changes would be beneficial to fully understand the effects of policy 
changes.
  
76 
 
Appendix A 
Below is an example of the legal-policy condition prompt which was shown to the 
participant immediately after randomization to condition. 
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Appendix B 
 
Below is an example of the legal-policy condition prompt which was shown to the 
participant at the top of each measure after randomization to condition. 
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